Interaction Between Nigro-Striatal Lesions and Drugs Affecting Dopamine Receptors by Hynes, Martin Dennis
University of Rhode Island 
DigitalCommons@URI 
Open Access Master's Theses 
1975 
Interaction Between Nigro-Striatal Lesions and Drugs Affecting 
Dopamine Receptors 
Martin Dennis Hynes 
University of Rhode Island 
Follow this and additional works at: https://digitalcommons.uri.edu/theses 
Recommended Citation 
Hynes, Martin Dennis, "Interaction Between Nigro-Striatal Lesions and Drugs Affecting Dopamine 
Receptors" (1975). Open Access Master's Theses. Paper 197. 
https://digitalcommons.uri.edu/theses/197 
This Thesis is brought to you for free and open access by DigitalCommons@URI. It has been accepted for inclusion 
in Open Access Master's Theses by an authorized administrator of DigitalCommons@URI. For more information, 
please contact digitalcommons@etal.uri.edu. 
INTERACTION BETWEEN NIGRO-STRIATAL LESIONS A..7\ffi DRUGS 
AFFECTING DOPAMINE RECEPTORS 
BY 
MARTIN DENNIS HYNES III 
A THESIS SUBMITTED IN PARTIAL FULFILLMENT OF THE 
REQTJIREM:F~NT FOR THE DEGREE OF 
MASTER OF SCIENCE 
IN 
PHARNACOLOGY At~D TOY..ICOLOGY 
UNIVERSITY OF RHODE ISLAND 
1975 
MASTER OF SCIENCE THESIS 
OF 
MARTIN DENNIS HYNES III 
Approved: 
Dean of the Graduate School 
UNIVERSITY OF RHODE ISLAND 
1975 
NIGRO-STRIATAL LESIONS A}ID DRUGS 
ABSTRACT 
Lesioning the nigro-striatal dopamine neuron system 
produces aphagia and adipsia with an intensity proportion-
al to the size of the lesion. Those rats which received 
small lesions produced by a 1 mA current for a 15 second 
duration of the nigro-striatal system initially lost weight 
and then spontaneously recovered from that loss. Pretreat-
ment with alpha-methyl-para-tyrosine (50 mg/kg) or halo-
peridol (0.4 mg/kg) given twice a day for a three-day pe-
riod prior to lesioning facilitated the recovery. When 
large lesions (2mA for JO sec) were used to destroy this 
dopaminergic neuron system, a severe aphagia and adipsia 
resulting in death occurred in all saline treated animals . 
Haloperidol (2 mg/kg) or morphine sulfate (JO mg/kg) in-
jected twice a day for six days preceding extensive nigro-
striatal destruction promoted survival. The pharmacologi-
cal denervation of dopaminergic receptors produced by 
haloperidol, morphine sulfate, or alpha-methyl-para-tyro-
sine prior to surgical destruction pf the nigro-striatal 
pathway i? felt to facilitate recovery. 
Symptoms of morphine withdrawal such as, wet shakes, 
ptosis, weight loss and hypothermia were enhanced when le-
sions were made in the nigro-striatal tract prior to and 
following the production of morphine dependence. This ex-
acerbation of the primary abstinence syndrome was seen at 
either of two different terminal doses of morphine sulfate. 
ii 
Apomorphine, a dopamine receptor stimulant,- was effective in 
reducing the withdrawal wet sha kes in these lesioned animals. 
The administration of apomorphine to intact withdrawn rats 
also resulted in a signi fi c ant decrease in wet shakes. The 
intensity of morphine withdrawal aggre ssion observed in re-
sponse to social grouping of the animals seventy-two hours 
after the termination of morphine administration was de-
creased by nigro-striatal lesioning. Destruction of the 
medial forebrain bundle in morphine dependent rats results 
in increased withdrawa l ptosis, temperature and weight loss. 
These results suggest a role for brain noradrenergic and 
dopaminergic neuronal syst ems in morphine withdrawal. In 
particular, withdra wal wet shakes seem to be related to 
dopaminergic mechanisms. 
iii 
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I. INTRODUCTION 
The exis tence of the nigro-striatal pathway arising in 
the substantia nigra and terminating in the neostriatum is 
well established by histological (Anden et al., 1964; Anden 
~al., 1965), biochemical (Anden et al., 1964; Poirier and 
Sourkes ,. 1965) and electromicroscopic (Hokfelt and Unger-
stedt, 1969) determinations. The nigro-striatal neuron sys-
tem is known to regulate the dopamine content o:f the neo-
striatum (Anden. et al., 1964; Anden et al., 1965). The phy-, 
siological importance of this system is evident froffi its in-
volvement in mo t or function, mental processes, thei'moregu-
lation and normal feeding behavior (Anden et al., 1966b; 
Fuxe et al., 1 970). The function of this dopamine system is 
particularly int eresting in connection with the actions of 
a number of psy c h opharmacological agents such a s apomorphine 
(Anden et al., 1967; Ernst, 1967), morphine (Puri et al., 
1973) and neuro1.eptics (Anden et al., 1971) which are known 
to in:f'luence dop aminergic function. The objective of this 
study is to investigate the interaction between the effects 
of lesioning the nigro-striatal neuron system and 
pharmacological agents affecting dopamine receptors. 
The ascending fibers of the nigro-striatal system 
originate mainly from the dopamine cell bodies situated in 
the zona compacta of the substantia nig ra. The fibers be-
1 
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come aggregated in a bundle situated just medial and ventro-
medial to the lernniscus medialis in the area of the nucleus 
ventralis tegmenti. This bundle lies dorso medial to the 
ventral part of the crus cerebri in the H2 area of Forel be-
fore it enters the ro s tral part of the crus cerebri. After 
entering the crus cerebri the tract diverges into the in-
ternal capsule to innervate the neostriatum (Anden et al., 
1964; Anden et al., 1965; Poirier and Sourkes, 1965; Faull 
and Laverty, 1969). This system is of great importance for 
normal movements and postures. The symptoms of rigidity, 
hypokinesia and tremor found in parkinsonism are probably 
due to the degeneration of the nigro-striatal system (Horny-
kiewicz, 1966). The pathophysiology of schizophrenia may 
be in part due to the activity of dopamine at its receptor 
sites in the striatum (Klawans et al., 1972). A role for 
dopamine neurons in thermoregulation has been suggested 
since apomorphine decreases body temperature via a central 
action (Fuxe and Sjogrist, 1972). The nig ro-striatal neu-
rons appear to be necessary for normal eating and drinking 
behavior (Ungerstedt, 1970, 1971; Oltsman and Harvey, 1972). 
Unilateral lesions of the corpus striatum or the nigro-
striatal dopamine system are known to produce asymmetric 
movements and postures (Poirier et al., 1965; Anden et al., 
1966). Lesioned animals show a pro~ounced rotational be-
havior which is linked to differences in dopamine receptor 
activity on two sides of the brain (Anden et al., 1966a). 
3 
Three to four days after unilateral removal· of the nigro-
striatal system there is a lack of orienting response to all 
sensory stimuli on the side contralateral to the lesion 
(Ungerstedt, 197J). The period from five days to two months 
after the operation is characterized by partial recovery of 
sensory function (Ungerstedt, 1973). Degeneration of the -
nigro-striatal system, bilaterally, in the rat has been 
shown to result in the development of adipsia and aphagia 
(Ungerstedt et al., 1970, 1971). Zigmond and Stricker (1972, 
1973) have al s o found that depletion of brain dopamine was 
critical for the production of adipsia and aphagia. The 
adipsic and aphagic syndrome seen after nigro-striatal de-
struction is severe and if not force-fed animals die several 
days after lesioning (Ungerstedt, 1970, 1971; Oltsman and 
Harvey, 1972). Force-fed animals recover from aphagia and 
adipsia, in a predictable sequence of stages culminating in 
the ability to maintain their body weight on food pellets 
and water (Marshall and Teitelbaum, 1973). Recovery of 
feeding behavior has been suggested to involve a denervation 
supersensitivity mechanism (Glick~ al., 1 9 72). Supersensi-
tivity may be defined as the phenomenon in which the amount 
of a neurotransmitter required to produce a given biological 
response is less than normal. Thus, the one consistent sign 
of supersensitivity is a shift to the left of the dose re-
sponse curve (Fleming~ al., 1973). 
Supersensitivity in addition to being a useful model 
in explaining recovery of feeding behavior has also been 
-------·---- -- ----- ·--- --······- · --- ··-. -
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forwarded to ' explaining dependence on narcotics (Jaffe and 
Sharpless, 1968; Collier, 1969). Based upon results from 
morphine withdrawal aggression it has been suggested that 
central dopamine receptors are supersensitized during chron-
ic morphine administration. Morphine withdrawal aggression 
in dependent animals can be selectively potentiated by 
dopaminergic stimulating agents and blocked by drugs which 
block dopamine receptors (Puri~ al., 1971; Lal and Puri, 
1972; Puri and Lal, 1973). Further evidence for the inter-
action between brain dopamine and morphine comes from bio-
chemical studies. Acute morphine elevates brain hornovanil-
lie acid and J- 4 dihydroxyphenylacetic acid (Fukui and 
Tagaki, 1972; Kus chinsky and Hornykiewicz, 1972), increases 
the synthesis of labeled dopamine from labeled tyrosine in 
brain (Clouet and Ratner, 1970; Fukui et al., 1972; Smith 
~ al., 1970, 1972 )' and accelerates the disappearance of 
dopamine after the administration of alpha-methyl-para-
tyrosine (Gunne ~ aJ_., 1969; Puri et al., 1973). Based up-
on these studies it was proposed that acute administration 
of morphine blocks dopamine receptors. Chronic administra-
tion of morphine therefore wo-uld produce a persistent bJ_ock-
ade of dopamine receptors and cause the development of lat-
ent supersensit i vity of central dopamine receptors. This 
supersensitivity may therefore contribute to the morphine 
withdrawal synd rome. 
Treatment with haloperidol (Gia.nutsos et al., 1974 a, 
1975) and methy l-para-tyrosine (Tarsy and Baldessarini, 1973) 
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has also been shown to produce a supersensitivity of dopamine 
receptors in the central nervous system. Haloperidol is a 
potent neuroleptic that is known to block dopamine recep-
tors (Janssen, 1967; Anden et al., 1971). The dopamine re-
ceptor supersensitivity produced by chronic administration 
.of haloperidol is manifested by an enhanced stereotypy and 
aggression in response to small otherwise ineffective doses 
of apomorphine (Gianutsos .!:..! al., l974a). Apomorphine has 
been sho>\TI to effectively decrease turnover of dopamine in 
haloperidol-treated rats at doses which were without effect 
in drug-naive rats (Gianutsos et~., 1975). A shift in 
the dose response curve in the direction of increased sensi-
tivity was found in response to apomorphine, a dopaminergic 
stimulant, after withdrawal of chronically administered 
alpha-methyl-para-tyrosine (Tarsy and Baldessarini, 1973). 
Alpha-methyl-para-tyrosine is a well known inhibitor of cate -
cholamine synthesis (Nagatsu et al., 1964). Apomorphine, 
which has been used in these studies to show increased sen-
si ti vi ty, is believed to stimulate the dopaminergic recep-
tors in the central nervous system (Anden et al., 1967; 
Ernst, 1967). Biochemical studies have shmvn that apomor-
phine decreases the turnover rate o~ striatal dopamine; this 
effect is completely blocked by haloperidol (Anden et al ., 
1967; Persson, 1970; Anden and Becard, 1971; Lahti et al., 
1972; Puri, 1973). 
This investigation is focused on the nigro-striatal neu-
ron system and dopaminergic supersensitivity. These factors 
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were studied in relation to aphagia, adipsia and the mor-
phine withdrawal syndrome. Nigro-striatal lesions will be 
made and body weight changes recorded. Frio~ to the produc-
tion of the lesion, animals will be treated with either 
saline, alpha-methyl-para-tyrosine, a blocker of catechol-
amine synthesis (Nagatsu et al., 1964), haloperidol, a dop-
aminergic blocking agent (Janssen, 1967; Van Rossum, 1967; 
Anden et al., 1970), or morphine which may also block dopa-
minergic receptors (Puri et~., l97J). Drug treated and 
cbntrol groups will be compared with respect to lesion in-
duced weight changes and lethality. 
Nigro-striatal lesions will be produced both prior to 
and subsequent to the production of morphine dependence. 
After the abrupt termination of morphine injections sub-
jects will be observed for the symptoms of morphine withdraw-
al. Narcotic withdrawal symptoms will be compared between 
lesioned and non-lesioned groups. The dopaminergic stimu-
lating agent apomorphine (Anden et al., 1967; Ernst, 1967) 
will be administered to both intact and nigro-striatal le-
sioned morphine withdrawn subjects to further assess the 
role of dopamine receptor activity in the abstinence phe-
nomena. In order to determine if the results are specific 
for the dopaminergic system the medial fore brain bundle, 
a nor-adrenergic and serotonergic neuron system, will also 
be lesioned after the production of dependence and absti-
nence signs observed. 
This research has the following significance. First-
7 
ly, evidence for the role of the nigro-str{atal dopamine neu-
rons in aphagia and adipsia will be gathered. Secondly, it 
will clarify the role of receptor supersensitivity in re-
covery from nigro-striatal lesioning and in the morphine 
withdrawal syndrome. 'Ihirdly, it will give insight into the 
role of this dopamine system in narcotic dependence. 
II. LITERATURE SURVEY 
A. Central Ne rvous Syst e m Dopaminergic Pathways 
The dopamine neuron system discovered so far are two 
large ascending fiber systems and one small dopamine neuron 
system. The existence of these dopaminergic pathways has 
been demonst ra ted through studies employi ng lesions, stimu-
lating electrodes, biochemical and histochemical techniques. 
Based upon these studies the following dopaminergic path-
ways have been described: 
1) Mesolimbic Dopamine Neur·Jns 
2) Tubero-infundibular Dopamine Neurons 
J) Nigro-Neostriatal Dopamine Neurons 
l) Mesolimbic Dopamine Neurons 
The mesolimbic dopamine neurons have their cell bodies 
in the area surrounding the nucleus interpeduncularis and 
fibers from these cell bodies terminate in the tuberculum 
olfactorium, nucleus accumbens, the dorsolateral part of the 
nucleus interstitialia striae terminalis and in the nucleus 
amygdaloideus centralis (Anden et al., l966a). Dopaminergic 
fibers of this system run medially to the nigro-neostriatal 
dopamine fibers whereas cranially they mainly lie ventral 
to the nigro-neostriatal dopamine fibers. The mesolimbic 
dopamine neurons probably contain less dopamine than does 
nigro-neostriatal dopamine neurons. This is probably due 
8 
to the fact that the terminal network of each mesolimbic 
dopamine neurons is much smaller than that of the nigro-
neostria tal dopamine neurons (Anden et ~.-, 1966b; Fuxe et 
al., 1970). 
9 
Lesions placed at the level of the rostral hypothala-
mus which specifically interrupt the pathway to the meso-
limbic area are found to modify neuroleptic catalepsy. 
These lesions caused an initial potentiation followed by a 
reduction in the cataleptic effect of neuroleptic agents 
but cause a potentiation of cholinergic catalepsy at all 
times of testing (Costall and Naylor, 1974). The mesolimb-
ic area thus appears to be involved with the mediation of 
neuroleptic catalepsy and the cholinergic dopaminergic bal-
ance controlling cataleptic beha~~br ~ould also appear to 
involve the mesolimbic dopamine neurons (Costall and Naylor, 
1974a). Lesions of the dopaminergic mesolimbic innervation 
partially reduce morphine catatonia (costall and Naylor, 
1974b). · Although stereotypy has been considered by many 
purely in terms of extrapyramidal actions, studies employ-
ing apomorphine and ET 495 have shown that mesolimbic func-
tions are important for the initiation of stereotyped re-
sponses (Costall and Naylor, 197Jc). Ablation of the mesa-
limbic innervation reduce the weaker components of methyl-
phenidate stereotypy (Costall and Naylor, 1974c). 
2) Tubero-infundibular Dopamine Neurons 
The tubero-infundibular dopamine neurons have their 
10 
cell bodies mainly localized to the anterior part of the 
nucleus annuatus and anterior periventricular nuclei. The 
axons of this system run ventrally toward the lateral b6rder 
of the median eminence (Fuxe, 1963; I<'uxe and Hokfelt, 1966, 
1969). In the external layer of the medial eminence, the 
axons give rise to a densely packed plexus of dopaminergic 
nerve terminals, which exerts ah axo-axonic influence in the 
layer (Hokfelt, 1967). 
This very short dopaminergic intrahypothalamic system 
regulates the discharge of the releasing and inhibiting fac-
tors from the median eminence (Fuxe ~al., 1970). The re-
lea8e of dopamine in the median eminence acts locally on 
terminals storing luteinizing hormone releasing factor 
(LHRF) to inhibit the release of LHRF from the medial emi-
nence. This system also participates in mediating the nega-
tive feedback action of estrogen and testosterone on gonado-
tropic secretion, because estrogen and testosterone markedly 
increase the turnover of the tubero-infundibular dopamine 
neurons of castrated rats, resulti·ng in increased release of 
dopamine in this area (Fuxe et al., 1967, 1969). The block-
ade of ovulation by synthetic estrogen and its derivatives 
may at least partly be mediated via activation of the neuron 
system (Fuxe and Hokfelt, 1969). This system is also high-
ly sensitive to prolactin, which markedly increases the 
turnover of dopamine in the tubero-infundibular dopamine 
neurons (Fuxe and Hokfelt, 1969, 1970). 
11 
J) Nigro-neostriatal Dopamine Neurons 
The nigro-neostriatal system seems to originate mainly 
in the pars compacta of the subst a ntia nigra (Anden, 1964). 
Support for this comes from fluorescence microscopy and the 
high dopamine content observed in this area (Hornykiewicz, 
1963). Unilateral pars compacta lesions result in a sixty 
per cent lowering of the dopamine level in the corpu~ stri-
atum of the operat~d side when compared with the unoperated 
side (Faull and Laverty, 1969). The caudate nucleus and 
putamen shows a fairly strong green to yellow fluorescence 
due to the high dopamine content. This fluorescence was re-
duced in animals with lesions of the substantia nigra. A 
clear correlation was found between the fluorescence reduc-
tion and the extent of destruction of the pars compacta 
(And en, 1964). Some cell bodies are also found in the zona 
reticulata and the pars lateralis of the substantia nigra, 
which also belong to the nigro-neostriatal dopamine neurons 
(Fuxe et al., 1970). Recently, studies after removal of the 
nucleus caudatus putamen suggest that the cell bodies in 
the ventrolateral part of the midbrain tegrnentum belong to 
this large uncrossed neuron system, inasmuch as they show 
marked reduction in fluorescence intensity and signs of 
atrophy after such operations (Fuxe et al., 1970). There 
is now a virtually complete picture of the distribution of 
these dopamine fibers. Upon leaving the pars compacta of 
the substantia nigra, most of the nigro-neostriatal dopamine 
12 
fibers become aggregated in a bundle which ascends just medi-
al and dorso medial to the ventral part of the crus cerebri. 
At the level of the posterior part of the medial eminence, 
the bundle turns to the ventralrostral part of the crus cer-
ebri and enters and diverges into the rentrolenticular part 
of the internal capsule. Running rostrally and dorsally in 
the internal capsule, the fibers then ascend in the fibers 
of the internal capsule to innerva te the neostriatum (Anden 
et al., 1965). 
Biochemical and histochemical investigation have 
yielded some quantitative data on the unilateral nigro~neo-
striatal dopamine system in the rat. The number of neurons 
making up this syst~m is 3500 on the average. There are 
-10 
about 1.2 x 10 . grams of dopamine per neuron with termi~ 
nals containing fifty times more dopamine than the cell 
bodies. There are approximately 500,000 varicosities in the 
terminals, each with an average diameter of 0.4u, containing 
-16 2.5 x 10 grams of dopamine and has a dopamine concentra-
tion of around 8,000 ug/grwet weight. One dopamine cell 
body of the substantia nigra, with a mean diameter of 30u, 
contains 2,5 -18 x 10 grams and has a dopamine concentra-
tion of from 60 to 200 ug/gr (Anden et al., 1966c). 
a. Electric stimulation of the nigro-neostriatal pathway 
The direct electrical stimulation of either the cau-
date nucleus or the pars compacta of the substantia nigra 
causes a frequency and intensity related release of H-3 
lJ 
dopamine into the cerebrospinal fluid (Von Voightlander and 
Moore, 1971, 1 9 72) and also into ventricles (Von Voightland-
er and Moore, 1971). These results imply that dopamine is 
a neurotransmitter of the nigro-neostriatal pathway. There 
is evidence to indicate that dopamine may function as an 
inhibitory neurotransmitter at the terminals of the nigro-· 
neostriatal pathway. Bloom et al., (1965), demonstrated a 
primarily i rihibi tory action of dopamine when it was applied 
micro-iontrophoretically to caudate neurons. Most of the 
neurons tha t respond to dopamine are inhibited by exogeneous 
dopamine applied in the caudate nucleus of anes.thetized and 
decerebrated cats {McLella n and York, 1967; York 1970). 
Following the application of dopamine iontrophoretically 
from multibarrel micropipette assemblies ne a r caudate cells, 
the rate of discharge of fifty to sixty per cent of these 
neurons is depressed, while the spike rate of approximately 
ten per cent of the cells is facilitated. Electrical stim-
ulation of substantia nigra evokes depressant and facil-
latory responses from individually recorded nucleus neu-
rons (Connor, 1968, 1970). 
Catecholamine involvement in the phenomenon of intra-
cranial self stimulation is well known. Until recently, the 
major role has been assigned to noradrenergic nerves. This 
has been challenged by neuroanatomical and histochemical 
evidence of a possible dopaminergic involvement in intra-
cranial self-stimulation (Phillips and Fibiger, 1973). When 
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the facilatory effects of d and l isomers of amphetamine on 
self-stimulation were assessed, it was found that the two 
isomers were equipotent (Phillips and Fibiger, l97J). These 
data would seem to indicate that the dopaminergic systems 
in part subserves positiv~ reinforcement. 
b. Motor functions 
The nigro-neostriatal neurons play an important role 
in normal movement and postures. Degeneration of the sys-
tern is believed to be the cause of symptoms such as rigid-
ity, hypokinesia and tremors found in parkinsonism (Horny-
kiewicz, 1966). In agreement with this it has been found 
possible to restore normal motor functions in Parkinsonian 
patients by treatment with L-dopa (Cotzias et al., 1967). 
The drug-induced stimulation of the nigro-neostriatal 
pathway causes an induction of locomotion, stereotyped be-
haviors and finally compulsive gnawing (Randrup and Munkvad, 
1968; Fuxe and Ungerstedt, 1970). Thus the changes in 
these behaviors involve the stimulation of dopaminergic re-
ceptors. Similar results were obtained when animals were 
treated with L-dopa, the precursor of dopamine, following 
dopa decarboxylase illl'J.ibi ti on. Locomotor activity was mark-
edly increased (Bartholini et al., 1969; Butcher et al., 
1970). The increase in locomotor activity is mainly com-
posed of stereotyped movements (Butcher et al., 1970). The 
systemic administration of apomorphine produces stereo-
typed behavior in rats which is characterized by continuous 
and compulsive sniffing, licking and gnawing (Ernst, 1965). 
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The results of several studies have supported the hypothesis 
that stereotyped behaviors induced by apomorphine or by 
amphetamine is due to increased dopamine receptors activity 
in the neostriatum (Ernst, 1969; Fuxe and Ungerstedt, 1970). 
Unilateral lesions of the corpus striatum or the nigrb-
striatal dopamine system are known to produce asymmetries in 
movemen t and posture (Poiri~r et al., 1965; Anden tl al., 
i966a) . The difference between the two sides of the brain 
may be further aggravated by treatment with drugs that re-
lease dopamine from the non-lesioned side. Such animals show 
a pronounced rotational behavior (Anden et al., 1966a). The 
rotational behavior is further linked to the differences in 
dopamine levels on the two sides of the brain by finding 
that tinilateral striatal injections o f dopamine cause the 
rats t o turn or slowly rotate away from the side where dopa-
mine was injected (Ungerstedt et al., 1969). Spontaneous 
rotatio ns toward the intact side is seen twenty-four to 
thirty-four hours after a lesion of the nigrostriatal dopa-
mine s y stem. The direction of the rotation as well as the 
time p o int of its occurrence is indicative of a degeneration 
release of dopamine from_ the lesioned side (Ungerstedt, 
1973). In a chronically lesioned animal there is a striking 
difference between the effects of dopamine-releasing drugs 
and dnpamine receptor-stimulating drugs. Amphetamine causes 
the ani mal to rotate toward its lesioned side, apomorphine 
causes .it to r o tate toward its intact side (Ungerstedt, 
1973). These r esuJ_ts indicate that amphetamine preferenti-
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ally influences the non-lesioned side, whereas apomorphine 
exerts its strongest effect on the denervated side. 
c. Mental functions 
It is now accepted that stereotyped behavior induced 
by amphetamine or apomorphine is principally due to the in-
creased dopaminergic neurotransmission in the neostriatum. 
Stereotyped behavior is also often seen in patients with 
schizophrenia. (Snyder, 1971) and it has, therefore, been as -
sumed to be partly due to an abnormal increased activity of 
nigro-neostriatal dopamine neurons (Fuxe et al., 1970). 
This view is substantiated by the fact that neuroleptics 
which are potent antipsychotic drugs block dopaminergic 
neurotransmission (Corrodi et al., 1971). 
d. Autonomic functions 
The observation that dopamine increases cardiac out-
put and increases systemic blood pressure (Noyer et al., 
1971) suggest that dopaminergic neurons may play a role in 
central vasomotor mechanism. Since the administration of 
dopaminergic blocking agents such as spiroperdal and pimo-
zide decrease blood pressure (Fuxe et al., 1970). 
e. Sensory neglect following removal of the nigrostriatal 
dopamine system 
Three to four days after ~ unilateral removal of the 
nigrostriatal system there is an almost complete lack of 
orienting response to all sensory stimuli on the side con-
tralateral to the J.esion, while the animal reacts in an es-
----·--,,___,..~-.- ..... _,_._- -· - .. _,,, __ . ~--- -·-~---~~-- ---
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sentially normal way to stimuli-to the side ipsilateral to 
the lesion (Ungerstedt, 1973). Simple reflexes like the 
withdrawal reaction or the corneal reflex, are normal on 
both side_s. The period from five days to two months after 
the operation is characterized by partial recovery of sen-
sory functions. Even two months after the operation none 
of the anim~ls show normal responses on the side contra-
lateral to the lesion. The sense of smell seems to recover 
first, then vision and yet none of the animals regained a 
normal reaction to touch (Ungerstedt, · 1973). 
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B. Adipsia and Aphagia After Degeneration ·Of the Nigro-
Striatal Dopamine System 
Detailed mapping of the central monoamine pathways 
(Ungerstedt, 1971) show the dopamine axons to be located in 
a dense bundle in the lateral hypo thalamus before entering 
into the crus cerebri. There is a vast literature in the 
field of physiological psychology and especially in connec-
tion with consumatory behavior where the effects of lesions 
and stimulations in this area are carefully studied. How-
ever, the dopamine system has received little or no atten-
tion, probably because detailed inf'orma tion of its anatomy 
has been lacking. 
A great deal has been learned concerning the changes 
in food and water r egulation follo wing lateral h y pothalamic · 
lesions; little is known concerning the spe cific anatomical 
structures or systems involved. Several investigations 
have suggested that the critical areas for producing the 
lateral hypothalamic syndrome may be outside or include on-
ly a lateral segment of the lateral hypothalamus (Morgane, 
1961; Gold, 1967; Grossman and Grossman, 1971; Wampler, 
1971). Gold (1967) outlined a critical forebrain area for 
producing aphagia and adipsia. This area included a portion 
of the g1obus pallidus, the medial portion of the internal 
capsule. It is known that several fiber systems pass 
through these three a reas which regulate the telancephalic 
content of norepinephrine , dopamine and serotonin. The 
nigro-striatal bundle, a fiber system that regulates the 
- --- ---- ...... . 
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dopamine content of the neostriatum, passes · through each of 
the three areas described by Gold (1967). 
_ Electrocoagulation in the lateral hypothalamus inter-
rupting the axons of the nigro-striatal dopamine pathway 
cause the dopamine terminals in the corpus striatum to de-
generate thus resulting in a decrease in the dopamine con-
tent of the neostriatum (Poirier et al., 1967; Faull and 
Laverty, 1969; Moore et al., 1971; Ungerstedt, 1971). Symp-
toms of adipsia and aphagia appear after the lesions; since 
other than dopamine neurons may have been destroyed the re-
sults may not be due to interruption of dopamine fibers 
alone. The technique of int~ocerebral injections of 6-hy-
droxydopamine permits a more selective degeneration ·of dopa-
mine and noradrenergic pathways (Ungerstedt, 1971). The 
development of adipsia and aphagia was correlated to the 
histochemical effects of the 6-hydroxydopamine lesions. 
Adipsia and aphagia always followed a complete bilateral de-
generation of the nigro-striatal dopamine system regardless 
if the 6-hydroxydopamine was injected into the substantia 
nigra, the area ventralis tegmenti or the lateral hypothal-
amus (Ungerstedt, 1970, 1971). However, where the ascending 
noradrenergic pathways were lesioned no adipsia and aphagia 
developed in spite of the fact that most of the hypothala-
mus degenerated (Ungerstedt, 1971). In agreement with 
~r~vious reports, intraventricular administration of 6-hy-
droxydopamine in monoamine oxidase inhibited · animals or bi-
lateral injections of 6-hydroxydopamine into substantia nigra 
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produced aphagia and adipsia (Fibiger ~al., 1973). Oltsman 
and Harvey (1972) found that electrolytic lesions of the lat-
eral hypothalamus which destroyed the dopaminergic nigro-
stria tal tract produced severe aphagia and adipsia. 
The adipsic and aphagic syndrome seen after nigro-stri-
atal destruction is severe. -ungerstedt ( 1970, 1971) found 
that if not supported, the animals died four to five days af-
ter lesions. Their condition was generally worse than that 
which is seen where a normal animal is deprived of food and 
water (Ungerstedt, 1971). Oltsman and Harvey (1972) also re-
ported a severe aphagia and adipsia after nigro-striatal 
lesioning. Recovery of food and water intake is re~orted to 
have occurred within ten days of intraventricular 6-hydroxy-
dopamine (Zigmond and Stricker, 1972; Fibiger et al., 1973). 
Nigral injections of 6-hydroxydopamine produce a more severe 
effect with recovery failing to occur during a three month 
period (Fibiger et al., 1973). Animals with nigro-striatal 
lesions show deficits in water regulation and food intake 
as have been found in lateral hypothalamic lesioned animals 
(Oltsman and Harvey, 1972; Fibiger et al., 1973; Marshall 
and Teitbaum, 1973). Rats with nigro-striatal destructions 
progress through the same sequence of stages in the recovery 
of feeding as do rats with lateral hypothalamic lesions 
(Marshall and Teitelbaum, 1973). 
Ungerstedt· (1970, 1971) has shown that adipsia and 
aphagia is the result of a loss in striatal dopamine. Zigmond 
and Stricker ( .1972, 1973) have also found that depletion of 
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brain dopamine was more critical for producing symptoms of 
the lateral hypothalamic sundrome than was depletion of brain 
norepinephrine. Glick et al., (1974) have found lesion-in-
duced weight loss to be highly correlated with depletion of 
striatal dopamine but not telencephalic norepinephrine. In 
rats with severe dopamine depletions, the degree of weight 
loss was related more to the striaturn with the highest re-
maining level of dopamine suggesting that a critical level of 
doi:>amine in one striatum may be essential for lateral hypo-
thalamic recovery. Zigmond and Stricker (1973) have also. 
r~ported that residual brain catecholamines appear to make 
a significant contribution to the recovery of ingestive be-
havior in rats with either 6-hydroxydopamine or electrolytic 
lesions. Rats after intraventricula r 6-hydroxydopamine or 
lateral hypothalamic lesions decrease food and water intake 
markedly after the administration of methyl-para-tyrosine a t 
doses that did not affect the ingestive behaviors df con-
trolled rats (Zigmond and Stricker, 1973). These results 
suggest that recovery from aphagia and adipsia is dependent 
upon compensatory processes occurring with the damaged sys-
terns. Severa.l mechanisms have been proposed which might 
account for this compensation, such as an increa.se in cate-
cholamine turnover in terminals of remaining fibers (Bloom 
et al., 1969; Uretsky ~al., 1 9 71), an increased sensitivity 
of postsynaptic receptors (Ungerstedt, 1971; Uretsky and 
Schoenfeld, 1971; Schoenfeld and Uretsky, 1972), and sprout-
ing of new terminals f rom transceted axons (Katzman~ al., 
---- ----·--··-··- ·- -·------·----- - -
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1971; Nygren et al., 1971) • 
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Recently, various kinds of chemical treatments have 
been found to attenuate the severity of the aphagia and adip-
sia following bilateral lesions of the lateral hypothalamus. 
Recovery of feeding behavior has been facilitated by systemic 
injections of either methyl-p-tyrosine or insulin for a few 
days prior to surgery. Rats with bilateral hypothalamic le-
sions die of starvation within seven days of surgery. But 
when these rats are pretreated with methyl-p-tyrosine they 
spontaneously eat, drink and gain weight after surgery (Glick 
et al., 1972). These data suggest that recovery of func-
tions after lateral hypothalamic damage involves denervation 
supersensitivity since, methyl-p-tyrosine should have phar-
macologically produced a partial denervatio~ of neurons sub-
serving recovery. Glick and Greenstein (1972) have also 
suggested that recovery from lateral hypothalamic lesions 
may involve the sprouting of intact inputs to the remaining 
lateral hypothalamic noradrenergic neurons. They found that 
if frontal cortical lesions were produced thirty days prior 
to lateral hypothalamic lesioning recovery was facilitated. 
The period of recovery after bilateral electrolytic lesions 
of the lateral hypothalamus is shortened if insulin is given 
for five days before surgery (Balagura et al., 1973). Re-
covery of feeding has also been facilitated when rats are 
reduced by food deprivation to seventy-five per cent of their 
normal body weight. This food deprivation facilitated re-
covery has been shown for lateral hypothalamic lesions 
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(Powley-Keesey, 1970) and 6-hydroxydopamine treatment (Myers 
and Martin, l97J). 
Enhanced recovery of feeding after hypothalamic damage 
.has been reported ~n response to an intraventricular injec-
tion of nerve growth factor (Berger et aJ_., 1973). These 
authors speculate that nerve growth factor may facilitate 
behavj_oral recovery by promoting the development of super-
sensi tivity to norepinephrine and possibly also by stimulat-
ing the growth of regenerating noradrenergic neurons in the 
brain. Postoperative alpha-methyl-para-tyrosine treatment 
has been sho>vn to facili:tate survival but the dose of alpha-
methyl-para-tyrosine which will produce this effect ;_s 
critical (Glick and Greenstein, 1974). Initially, alpha-
methyl-para-tyrosine improved feeding mechanisms involving 
catecholamine and thereby promoted the development of de-
nervation supersensitivity which became behaviorally mani-
fested after the effect of alpha-methyl-para-tyrosine on 
catecholamine synthesis had subsided (Glick and Greenstein, 
1974). Electrical stimulation through the same electrodes 
that induced aphagia by means of a mechanical lesion has been 
shown to shorten the post lesion recovery period (Harrell 
et al •. , 1974). Alteration of the esculent property of the 
diet given f'ollowing lateral hypothalamic lesioning has also 
been shown. to e f:t·ect recovery from the syndrorne (Myers and 
Martin, 1973). Recovery of a postoperative weight loss fol-
lowing bilateral ablations of frontal cortex in rats is 
quicker when food pellets are scattered on the cage floor 
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than when pellets were available only in attached food hop-
pers (Glick and Greenstein, 197J). The period of recovery 
after bilateral electrolytic lesions of the lateral hypo-
thalamus in r ats is lengthened if gluc agon is given during 
the preoperative period (Balagura et a l., 197J). Bilateral 
lesions made in the habenular nuclei had little effect on 
recovery of feeding following lateral hypothalamic lesions 
(Mok et ·al., 1973), thus suggesting that the habenular 
nucleus is not a crucial part of the feeding syst.em which 
mediates the recovery from the lateral hypothalamic syndrome. 
C. Cortical Dopaminergic Terminals 
For a number of years it had been generally assumed 
that all catecholaminergic cortical nerve terminals were 
nor-adrenergic. However, high concentrations of dopamine 
have been found in the cortex of various species (Bertler 
and Rosengren, 1959; Valzelli and Garatlini, 1968). It ap-
pears that most of the dopamine found in the cortex of the 
rat is not localized in nor-adre nerg ic terminals. Lesions 
of the dorsal nor-adrenergic system or a combined lesion 
of the dorsal and the ventral nor-adrenergic systems, which 
both significantly decrease the cortical levels of nore-
pinephrine, did not induce a parallel reduction in cortical 
dopamine content (Thierry!:..!. al., 197Jb). These findings 
strongly suggest the existence of dopaminergic neurons in 
the cortex. Further evidence for the e xistence of dopa-
minergic terminals in the rat cortex is taken from the fact 
that cortical synaptosomes have the ability to synthesize 
JR-dopamine from JR-tyrosine (Thierry tl al., 197Ja). 
The destruction of ascending noradrenergic pathways which 
abolishes the in vitro synthesis of JR-norepinephrine did 
not abolish the synthesis of JR-dopamine (Thierry et al., 
197Ja). Also, a specific dopamine reuptake process has 
been demonstrated in the cerebrc'fl ·cortex of normal rats 
and rats whose ascending noradrenergic pathways have been 
selectively destroyed (Tassin et al., 1974). Visualiza-
tion of these dopaminergic terminals has been achieved by 
combined pharmacological and histochemical methods 
(Lidbrink tl al., 1974). The occurrence of dopaminergic 
nerve endings was further ~upported by the demonstration 
of a dopaminergic receptor in the cortex. Specifically, 
dopamine was found to activate an adenylate cyclase sys-
tern and this effect was inhibited by the dopamine recep-
tors blocker haloperidol {van Rungen and Roberts, 197J). 
D. Recovery Mechanism Within the Central Nervous System 
Recovery from central nervous system lesions appears 
to be dependent on compensatory processes occurring with-
in the damaged system. Several mechanisms have been pro-
posed which might account for this compensation; such as 
an increase in catecholamine turnover in terminals of re-
maining fibers, an increase in sensitivity of postsynaptic 
receptors and sprouting of new terminals from transected 
axons. 
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1) Catecholamine Turnover 
Reduced accumulation of intraventricularly adminis-
tered 3H-l-norepinephrine was seen in the brain of rats 
who were treated with intraventricular injections of 6-
hydroxydopamine. The loss of catecholamine uptake sites 
produced by the 6-hydroxydopamine pretreatment was prob-
ably responsible for the reduction in accumulation 
(Uretsky et al., 1971) • . The rate constant of disappear-
ance of 3H-norepinephrine was used to estimate the frac-
tion of the endogenous norepinephrine pool turning over 
per unit of time. An increase in the rate constant in 
the pons-medulla region was seen in 6-hydroxydopamine 
treateci·rats. An increase in the rate constant may indi-
cate that norepinephrine containing neurons which survive 
the degeneration effects of 6-hydroxydopamine show an 
increase in their physiological state of activity to com-
pensa t e for the loss of neuronal function after degener-
ation ( Uretsky ~al., 1971). Alternatively, the nor-
adrenergic neurons which have a higher turnover than aver-
age may survive the effects of 6-hydroxydopamine. Since 
6-hydroxydopamine causes a profound and long-lasting de-
pletion of norepinephrine in all . brain r e gions . (Uretsky 
and Ive rsen, 1 970), the t urnover rat e of norepinephrine in 
6-hydroxydopamine pretreated animals was much lower than 
in cont rol brains despite the increase in rate constant 
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observed in the pons-medulla (Uretsky .£.!.al., l97l). These 
results are consistent with those of' Bloom et al. (1969), 
who found a decrease in the turnover of norepinephrine in 
whole brain of 6-hydroxydopamine treated rats. In these 
experiments there was an increase in the rate constant in 
the striatum; this reflects the disappearance of 3H-no-
repinephrine from mainly dopaminergic neurons. This in -
crease in the rate constant may nevertheless reflect some 
compensatory change in the level of activity of the sur-
viving dopamine-containing neurons. 
A marked increase in dopamine specific activity has 
been found after intravenous administration of 3H-tyrosine 
in animals following injections of 6-hydroxydopamine in to 
the substantia nigra. Furthermore, these lesioned animals 
showed enhancement of the 3H-H2 0/DA rg_tio on the lesioned 
side following injections of the radioactive precursor. 
An increase in the ratio of homovanillic acid to the dop-
amine content in the striatum on the side lesioned with 
6-hydroxydopamine has also been found (Agid et al., 1974). 
These results indicate a hyperactivity of the remaining 
dopaminergic neurons following partial degeneration of 
the nigrostriatal pathway. 
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2) Postjunctional Supersensitivity 
Supersensitivity may be defined as the phenomenon in 
which the amount of a substance required to produce a given 
Thus, the one 
shift in the maxi-
biological response is less than normal. 
consistent sign of supersensitivity is a 
mum response to a drug (Fleming et al., 1973). An apparent 
change in sensitivity of the postjunctional element to nerve 
impulses could result from any one of several changes in 
the transmission apparatus. There could be a change in the 
postjunctional element so that it actually became more sen-
sitive to the transmitter (Thesleff, 1960). The mechanism 
inactivating the transmitter could change so that it is re-
moved from its site of action more slowly (Trendelenburg, 
1963). Prejunctional elements could increase their capacity 
to deliver transmitter or change their recovery process to 
repetitive stimulation (Sharpless, 1969). Many of these 
changes are known to occur in disused or denervated periph-
eral structures. 
There is evidence that spinal motor neurons become 
more reactive to a variety of stimuli following cord section 
(Cannon and Rosenblueth, 1949; Stavraky, 1961), and destruc-
tion of sensory nerve fibers (Cannon ·and Rosenblueth, 1949; 
Stavraky, 1961; Loeser and Ward, 1967). Several weeks after 
a tenotomy, which relieves tension on muscle spindles and 
thus reduces the activity of Group la sensory fibers, mono-
synaptic discharge elicited by stimulating Group la fibers 
had greatly increased j_n strength (Beranek and Hnik, 1959; 
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Kozak and Westerman, 1961). 
Supersensitivity of the temperature regulating center 
of the hypothalamus has been shown to develop in response 
to chronic administration of scopola~ine (Friedman and 
Jaffe ·, 1969; Friedman et al., 1969). When scopolamine was 
administered to mice for various periods ranging from five 
days to four weeks and then withdrawn, an exaggerated hypo-
thermic response to pilocarpine and other centrally acting 
cholinergic drugs was seen. Sharpless and Halpern (1962) 
found that in the isolated cerebral cortex of the cat su-
persensitivity emerged in two to three weeks after surgical 
denervation. Supersensitivity to metamphetamine has been 
shown to occur after treatment with alpha-methyl-para-tyro-
sine (Paschel and Nintemon, 1966). 
Following intraventricular administration of 6-hy-
droxy-dopamine which destroys catecholamine containing nerve 
terminals, L-dihydroxy-phenylalanine (dopa) produces a 
marked increase in the locomotor activity of treated rats, 
while it has little effect on the activity of untreated rats 
(Uretsky and Schoenfeld, 1971). These results suggest the 
enhanced effects of L-dopa may be due to a central super-
sensitivity to catecholamine. The behavtoral response to 
apomorphine is altered by 6-hydroxydopamine pretreatment 
while lowering the ED50 for apomorphine (Schoenfeld and 
Uretsky, 1972). A modified response to apomorphine, ad-
ministered directly into the striatum has also been reported 
in reserpine-treated rats (Fuxe and Ungerstedt, 1970). 
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Jalfre and Haefely (1971) have reported that 6-hydroxydop-
amine treated rat.s s howed increased motor activity after low 
doses of apomorphine which were inefr ective in normal ani-
mals. A shift i n the dose-response curve in the direction 
of increased sens itivity was found in response to apomor-
phine after withdrawal of chronically administered reserpine, 
alpha-methyl-para-tyrosi.ne or chlorpromazine (Tarsy and 
Baldessarini, l97J). Chronic administration of haloperidol 
has been shown to result in a supersensitivity of dopamine 
receptors .. This supersensitivity is manifested by an en-
hanced stereotypy and aggression in response to small, other-
wise ineffective doses of apomorphine (Gianutsos et al., 
1974). Apomorphine has been shown to effectively decrease 
turnover of dopamine in haloperidol treated rats at doses 
which were without effect in drug-naive rats (Gianutsos et 
al. , 1971+) • 
Chronic den ervation of the rat pineal gland leads to 
an increase in the cyclic AMP response to norepinephrine 
within three weeks (Weiss and Costa, 1967). Pineal denerva-
tion has been shown to also induce supersensitivity in the 
postsynaptic beta adrenergic receptor site on the pineal 
cell to catecholamines. Elevation of adenosine cyclic 3', 
5' monophosphate was also seen in response to denervation 
and this resulted in the superinduction of N-acetyl-trans-
ferase in the p i neal gland (Deguchi and Axelrod, 1973). The 
responsiveness of the pineal beta adrenergic receptor has 
been found to cha nge sensitivity, in response to diurnal 
Jl 
changes (Rom~ro and _.<\xelrod, l974). An increase in the cy-
clic AMP response to norepinephrine has been found to occur· 
in the hypothalamus, cerebrum and brainstem of rats treated 
seven days beforehand with 6-hydroxy-dopamine (Palmer, 
l972). Prior to destruction of the dopamin~rgic innerva-
tion in the striqtum by 6-hydroxydopamine or chronic inhibi-
tion of dopamine synthesis by alpha-methyl-para-tyrosine 
fails to alter dopamine stimulated cyclic AMP formation. 
These results indicate that dopamine sensitive adenyl c·yclase 
does not ap~ear to increase during dopaminergic denervation 
supersensitivity (Von Voigtlander et al., l97J). 
A model proposed for physical dependence and associ-
ated tolerance is what Emmlin (l961) called the supersensi---
tivity 0£ pharmacological denervation. According to the 
disuse theory of physical dependence, presence of the drug 
entity is only indirectly responsible for the development of 
dependence; the direct or proximal cause is depression of 
nervous activity for long periods of time (Sharpless, 1969). 
Withdrawal phenomena generally seem to represent rebound 
effects, opposite in character to those produced by the drug 
itself, as if depressed pathways· become hyperexcitable dur-
ing withdrawal and stimulated pathways become -depressed 
(Sharple~s, 1969). Sharpless and Halpern (1962) suggest 
that supersensitivity of receptors might underly the convul-
sions resulting from withdrawal of barbituates after the in-
duction of physical dependence. It has also been suggested 
to account for physical dependence and tolerance towards 
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morphine (Jaffee, 1965; Collier, 1966). The effectiveness 
of apomorphine and amphetamine in enhancing morphine with-
drawal aggression when given in otherwise ineffective doses 
has led Lal and co-workers to suggest receptor supersensi-
tivi ty during narcotic dependence (Lal et al., 1971; Lal and 
Puri, 1972; Puri and . Lal, l97J). 
3) Evidence for Regeneration Axon Sprouting of Central Cate-
cholamine Neurons 
For many years a general conclusion of neurohistologi-
cal investigators was that adult manunal cerebral nerve fi-
bers show only feeble and abortive regenerative growth when 
sev~red (Cajal, 1928; Clark, l94J). 
ported sprouting from cut central 
Thus, many have re-
axons, but this process 
soon terminated and the newly formed axons sprouts were de-
scribed as degenerating within a few weeks. There is now 
d a ta to suggest the brain may be capable of some plastic 
modifications in response to deafferenting lesions; there 
is now evidence for more persistent a nd functional regener-
ation. 
It is well known that upon severing or traumatizing 
a monoamine nerve axon or an axon collateral, the trans-
mitter accumulates within the axon itself (Dahlstrom and · 
Fuxe, 1964; Dahlstrom, 1965). In fact, it is this phenome-
non that has permitted the mapping out of catecholamine-con-
taining fibers tracts in the central nervous system. The 
intraaxonal catecholamines accumulate very rapidly after 
the injury and remain approximately twelve days after which 
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they gradually disappear (Dahlstrom and Fuxe, 1965). During 
the seventh to nineteenth days after electrolytic lesions 
in the mesencephalon of the r~t a type of densely packed, 
delicate, fl .uorescent, vancose fiber become visible in the 
vicinity of the axonal accumulations (Katzman et al., 1971). 
This increase is ascribed to _regeneratio:h or sprouting of 
catecholamine fibe~s ~t the border of the l~sion. Although 
the catecholamine fluorescence in this fiber on the border 
of the lesion had decreased at seven weeks, the normal cate-
cholamine concentration in the preterminal part of the axon 
is too low to be visualized with the histochemical method 
(Ke.tzman et al., 1971). 
--
These newly formed fibers could ei-
ther represent the growth of the central catecholamine neu-
rons, whose axons have been cut by the lesion, or sprouting 
from the intact axons passing near the lesion. Studies em-
ploying lesions in the rat spinal cord show the development 
and growth of newly formed fiber sprouts from severed axons 
(Katzman et al •. , 1971; Bjorklund et al . , 1971). Reinnerva-
tion of the distal part of the spinal cord by new noradre-
nergic fibers following 6-hydroxydopamine denervation has 
been shown (Nygren et al., 1971). Reinnervation was attri-
buted to resrilt from outgrowth of axotomized fibers, but 
growth in the form of collaterals . sprouting from a few 
possibly surviving fibers in the distal region may be in-
valved. A normal pattern of innervation was seen within 
one to two months after denervation (Nygren et al., 1971). 
After a unilateral entorhinal lesion (a major extrin-
sic afferent to the hippocampal formation), a new fiber pro-
jection from the remaining contralateral entorhinial cortex 
grows to reinnervate the dentate gyrus. These new fibers 
establish electrophysiologically functional synaptic connec-
tions with the denervated dentate granule cells (steward et 
al., 1974). These results indicate that reinnervation has 
functional significance and that the reinnervating fibers 
may be functionally homologous to those which were destroyed 
by the lesions. The manner of .reinnervation by contralater-
al entorhinal fibers also suggest that the growing fibers 
are guided to the denervated site (steward et al., 1974). 
Col.1_ateral reinnervation has l;>een shown after partial deaf-
ferentation of the septal nuclei. It is a predictable phe-
nomenon, which follows a rigid time course and results in a 
characteristic pattern of synapse formation (Raisrnan and 
Field, 1973). Abundant growth of nerve fibers into and 
across thin laminar lesions of the rabbit cortex have been 
reported by Rose et al. (1960). Another case of significant 
neuronal regeneration has been reported in the hypothalamo-
hypophys ial tract after pituitary stalk transection in the 
ferret (1968). Lesioned central catecholamine neurons in 
the rostral mesencephalon show a considerable capac~ty for 
growth into smooth muscle transplants and into and along 
the walls of cerebral blood vessels (Bjorklund and Stenevi, 
1971). 
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E. Morphine and Brain Dopamine 
The relationship between neurotransmitters in the brain 
and the pharmacological activity of narcotic analgesics has 
received considerable attention in the last several years. 
S~rotonin, acetylcholine, norepinephrine and dopamine are 
among the neurotransmitters that have been implicated in the 
effect of morphine. 
l) Acute Effects of Morphine 
Morphine in a dose of 20 mg/kg has been shown to cause 
a thirty-two per cent decrease in mouse brain dopamine and 
twenty-three per cent decrease in norepinephrine when as-
sayed fluorometrically. The time course of this effect on 
dopamine is seen to correspond to analgesia produced by mor-
phine (Takagi et al., 1966). The acute adininistration of 
morphine has been shown by others to cause a similar decrease 
of brain dopamine as well as norepinephrine in mice (Reis 
et al., 1969; Rethy et al., 1971.). In rats, there was no 
difference in the brain dopamine levels one hour after an 
acute dose of morphine (Gunne et al., 1969; Wantanabe et al., 
1969; Johnson and Clouet, 1973; Puri et al., 1973}. How-
ever, a transient increase in dopamine levels at two and 
four hours after morphine has been reported (Johnson and 
Clouet, 197 3). 
14 . 14 The conversion of C-tyrosine in vivo into C-c·ate-
cholamines has been shown to increase after the acute ad-
ministration of either morphine or levorphenol (Smith et 
l 1970 ·197 ) · d · t· · f 14c t · ~., , 2 • The increase incorpora ion o - yrosine 
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. t 14 in o C-catecholamine was seen in the whol.e brain of mice 
after JO mg/kg or 100 Iµg/kg of morphine (Smith~ al., 1970, 
1972). Morphine was found to increase the synthesis of 
catecholamines ·in the cerebral cortex, diencephalon, stri.-
aturn, brainstem and cerebellwn. Naloxone, a narcotic antag-
onist, blocked the effects of morphine upon the incorporation 
of 14c-tyrosine into 14c-catecholamines. Tolerance has been 
shown to occur to this effect of morphine (Smith~ al., 
1972). Clouet and Ratner (1970) found that acute morphine 
administration increased the accumulation of 14c-dopamine, 
when 14c-tyrosine was injected cisternally. A maximum in-
crease was reached in the striatum and hypothalamus one hour 
after morphine administration. Enhanced accwnulation of JH-
dopamine was seen after the i.v. administration of C-J,5-H-
tyrosine in rats treated with morphine. Increased accwnula-
tion of 3H-dopamine and 3H-H2 0 was seen in tissue and mediwn 
of striatal slices incubated with 3H-tyrosine in response to 
morphine treatment (Gauchy et al., 1973). These results in-
dicate that morphine stimulated dopamine synthesis. In-
creased release of newly synthesized JH-dopamine was also 
seen which was evidenced by a greater accwnulation of JH-
dopamine in incubating mediwn of slices of morphine pre-
treated rats (Gauchy ~al., 1973). Similar results of in-
crease in the synthesis of dopamine and reversal by naloxone 
were also observed by Loh et al. (1973). 
Another pharmacological approach to study catechol-
amine turnover is the use of a catecholamine synthesis in-
··--·---·~---------
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hibitor, alpha-methyl-para-tyrosine. Acute administration 
of morphine has been found to cause an accelerated depletion 
of brain dopamine after catecholamine synthesis inhibi"tion~ 
This effect is interpreted as an increased activity within 
the ascending dopamine neuron system (Gunne et al., 1969). 
Similarly, Puri et al . (1973) · have sho·wn °a faster depletion 
of striatal dopamine by morphine in methyl-para-tyrosine 
treated rats, suggesting an increased dopamine turnover. 
Kuschinsky (1973) has also shown morphine to significantly 
increase the depleting effect of methyl-para-tyrosine. 
In rats, the catalepsy induced by analgesic doses of 
morphine has been shown to parallel a dose-dependent in-
crease in the concentrations of homovanillic acid, a dopa-
mine metabolite, in the striatum (Kuschinsky tl al., 1972, 
1974 and Ahtee et al., 1973). In the who le mouse brain 
Fukui and Tukagi ·(1972) have found a significant rise in 
the dopamine metabolites, homovanillic. acid and J,4-dihy-
droxyphenyl acetic acid, with analgesic doses of morphine. 
This increase in homovanillic acid is explained by an in-
creased dopamine turnover, thus a rise in dopamine utiliza-
tion in the striata (Kuschinsky, 1973 and Kuschinsky et al. , 
1974). The catalepsy and the ri$e in striatal homoyanillic 
acid concentrations produced by morphine were inhibited by 
naloxone (Kuschinsky et al.; 1972) a morphine antagonist, 
--
whereas the corresponding effects of chlorpromazine were 
not influenced by the nalaxone. Morphine had an additional 
effect on striatal homovanillic acid increase when combined 
-J8 
with a maximally effective dose of chlorpromazine (Kuschinsky 
et al., 1974). These results are interpreted to suggest that 
it is unlikely that morphine excited its effects on homova-
nillic acid in a manner like chlorpromazine {Kuschinsky e t 
al. 1974). They conclude that the main site of morphine's 
- action may be presynaptic, where the drug might interfere 
directly or indirectly with the metabolism of dopamine at 
the corresponding terminals. 
On the basis of their studies with methadone, Sasame 
et al. (1972) have postulated that the cataleptic effect 
and the increase of dopamine utilization, induced by narcot-
ic analgesics, are due to a postsynaptic dopamine receptor 
blocking effect. Puri et ~· {1973) have also argu~d for 
a postsynaptic blocking effect of morphine. They have shm.,n 
that morphine treatment blocked stereotYPed behavior in rats 
induced by amphetamine or apomorphine which are due to sti-
mulation of dopamine receptors. Further evidence that mor-
phine acts as a dopaminergic receptor blocker comes from 
the stud y of asynunetrics and turning produced in rats after 
unilateral removal of the caudate nucleus or lesioning of 
the nigro-striatal dopamine neurons. Morphine in a dose of 
· 2 mg/kg caused asymmetry to the operated side, as did halo-
peridol (5 mg/kg ) a known dopaminergic blocking agent (Fu.xe 
and Ungerstedt, 1970). This data along with the blockade by 
morphine of amphetamine and apomorphine induced stereotyped 
behavior {Fu.xe and Ungerstedt, 197.0; Puri tl al., 1973) sup-
port the view that morphine acutely acts as a dopamine 
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receptor blocker. Such a blockade can explain the. increased 
t .urnover found in the ascending dopamine neurons after mor-
phine (Gunne ~al., 1969; Puri et al., 1973). The blockade 
of dopamine receptors could induce a compensatory nervous 
feedback onto the presynaptic dopamine cell bodies in the 
mesencephalon. This will result in an increased nervous im-
pulse flow in dopamine neurons, which would result in in-
creased dopamine turnover (Fuxe and Ungerstedt, 1970). 
The intehsity of the catecholamine fluorescence mea-
sured in nerve cells of substantia nj_gra, ventromedial teg-
mental area, and midbrain reticular formation by a modifica-
tion of the histochemical method of Falck and Hillorp showed 
increased intensity in the male mouse in response to 40 mg/ 
kg of morphine (Heihrich et a l., 1971). In female rats on-
ly the cells of the substantia nigra showed a rise in 
fluorescence intensity after 20 mg/kg of morphine (Heinrich 
et al., 1971). Gunne et al. (1 969) have shown that acute 
morphine plus methyl-para-tyrosine produced an increased de-
pletion of fluorescence from the dopamine terminals in the 
nucleus caudatus putamen, nucleus accumbens and terberculum 
olfactorium. No change in the degree of depletion in vari-
ous noradrenergic terminals systems was seen after methyl-
para-tyrosine (Gunne !:.! al., 1 969). This change in fluo-
rescence appears to be due to an enhancement of amine syn-
thesis. 
Subanalgetic levels of morphine have been shown to 
produce mixed inhibitions of dopamine transport into slices 
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from the mouse brain cortex and uncompetitive inhibition in 
the diencephalon. Increased concentrations of morphine pro-
duced a greater effect on dopamine affinity rather than re-
action velocity which was observed in the cortex although 
inhibition remained mixed. In the diencephalon the type of 
inhibition changed from uncompetitive to mixed kinetics 
(Hitzemann et al., 1973). mi... t k f 14c d · · · t iue up a e o - opamine in o 
· t · · t d f 14c · · h · · t ra't s riaturn synap osomes an o -norepinep rine in o 
hypothalamic synaptosomes was inhibited by morphine in con-
cent rations -5 .,.6 of 10 and 10 M, respectively. Kinectic 
analyses of dopamine uptake in the presence of morphine sug-
gest that low affinity uptake was inhibited rather than high 
affinity uptake (Clouet et al., 1974). 
The in vitro and 1:E_ vivo activity of tyrosine hydroxyl-
ase after the administration of morphine has been studied by 
measuring the · f 14c t · t o d t conversion o - yrosine o D PA an ca e-
cholamines (Fuxe et al., 1972; Lok et al., 1973). 
Morphine did not modify the activity of tyrosine hy-
droxylase in brain homogenates. In vivo experiments show a 
significant increase in brain tyrosine hydroxylase activity 
after morphine. The authors suggest that an acceleration 
of dopamine biosynthesis may be due to the activation of 
feedback mechanism in vivo. 
----
Furthermore, a significant in-
crease in the specific activity of brain tyrosine was ob-
served after morphine, by other investigators and they also 
found this effect was blocked by the morphine antagonist, 
naloxone (Loh et al., 1973). 
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2) Effects of Chronic Morphine 
Gunne (1963) noted no change in dopamine content in 
the telencephalon of dogs treated daily for seventy to nine~ 
ty days with increasing doses of morphine up to 120 mg/kg~ 
Dopamine was also found unchanged in various brain regions 
of the morphine dependent monkey (Segal~ al., 1962; Segal. 
-et al., 1972). During chronic administration of morphine 
its effect on brain dopamine disappear~d and the impulse flow 
became . normal within ascending dopamine neurons system 
(Gunne et al., 1969). --- In rats, there was a slight increase 
in the brain levels_ of dopamine after chronic administration _ 
of morphine (Sloan et al., 1963; Johnson and Clouet, 1973). 
The increase in brain dopamine concentrations was suggested 
to be attributed to the increase in the syni;besis of dopa-
mine after chronic administration of morphine (Clouet and 
Ratner, 1970; Johnson and Clouet, 1973). The incr-ease in 
dopamine synthesis was suggested to be associated with the 
increase in tyrosine hydroxylase activityafter chronic mor-· 
phine (Reis~ al., 1970). Contrary to these findings 
Smith et ~· (1972) have shmm. that after repeated adminis-
tration of either morphine or levorphenol tolerance and 
cross tolerance developed to the effect of these drugs upon 
th t f 14c · d 14c · h · It e syn hesis o -dopamine an -norepinep rine. 
is interesting to note that the excretion of dopamine was 
reported to be increased in rats (Sloan and Eisen.men, 1968) 
and male human volunteers (Weil-Malberbe ~al., 1965) ·dur-
ing the addiction phase. 
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3) Effect of Morphine Withdrawal 
Gunne (1963) reported that brain dopamine was decreased 
seventy-two hours after morphine withdrawal. At this period 
dogs exhibited moderate to severe abstinence. Maynert and 
Klingman (1962) observed similar findings during withdrawal 
in dogs and rabbits but observed no change in brain dopamine 
on rats during withdrawal from morphine. Abrupt withdrawal 
has been shown to reduce activity in the brain dopamine neu-
rons. Histochemical results showed that methyl-para-tyro-
sine did not cause any effect within the dopamine or nor-
adrenergic neurons that could be distingui.shed from the 
effect of synthesis inhibition alone. Nalorphine-injuced 
abstinence caused increased activity within the noradrena-
line neuron system in practically all parts of the brain 
(Gunne et al., 1969). Contrary to this study a transient 
increase in dopamine levels was reported in rats and mice 
after naloxone induced withdrawal (Iwamoto~ al., 1973), 
which is suggested to be responsible for the stereotyped 
jumping in mice and rats during withdrawal. In rats, brain 
dopamine and norepinephrine levels decreased during with-
drawal from morphine when compared with chronic morphine 
levels (Sloan et al., 1973). The striatal dopamine turn-
over in morphine dependent animals was shown not to differ 
from the turnover in non-dependent animals when measured 
one, twenty-four and seventy-two hours after the last mor-
phine injection (Puri, 1973). Also, dopamine levels were 
4'.3 
replenished at a more rapid rate during morphine withdrawal 
after the administration of reserpine (Gunne et al., 1970). 
The urinary excretion of dopamine in rats was in-
creased during withdrawal with peaks occurring on the third 
and eighth day (Sloan and Eiseman, 1968). In humans, how-
ever, ·the urinary excretion of dopamine was found to be de-
creased during the withdrawal phase (Weil-Malherbe .£.!_al., 
1965). 
Upon withdrawal from morphine, aggregation of the de-
pendent rats elicited intense aggression. Pretreatment of 
the withdrawn rats with L-dopa, amphetamine or apomorphine 
before aggregation enhanced the aggressive response~ several-
fold. Haloperidol, a dopaminergic blocking agent, blocked 
the aggressive behavior (Lal et al., 1971; Puri et al., 
1971; Lal and Puri, 1972; Puri and Lal, 1973; Gianutsos 
et al., 1974). These data are interpreted to suggest a 
dopaminergic basis ()f morphine withdrawal aggression and 
the development of a latent supersensitivity of dopaminer-
gic neuropathways during morphine dependence. 
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F. Apomorphine and Brain Dopamine 
In both the central nervous system and in the periphery, 
apomorphine is believed to stimulate the dopaminergic recep-
tors (Anden et al., 1967; Ernst, 1967). Biochemical studies 
have shown that apomorphine decreases the turnover rate of 
striatal dopamine. The incorporation of C-14 tyrosine into 
dopamine was found to be decreased after the administration 
of apomorphine (Persson, J.970; Nyback et al., 1970). Apo-
morphine also decreases the disappearance of dopamine after 
alpha-methyl-para-tyrosine (Anden ~al., 1967; Anden and 
Bedard, 1971; Puri~ al., l97J). Similarly, there was a 
decrease in the rate of form~tion of homovanillic acid 
{Roos, 1965, 1969; Lahti et al., 1972). The administration 
of apornorphine can also result in the decreased accumula-
tion of dopa after the administration of NSD 1025 (Koe, 
1973). The biochemical changes of brain dopamine produced 
by apomorphine were completely blocked by haloperidol (Anden 
et al., 1967; Persson, 1970; Anden and Bedard, 1971; Lahti 
et a 1 • , 19 7 2 ; Puri et a 1 • , l 9 7 J ) • Apomorphine has also 
been shown to inhibit tyrosine hydroxylase activity direct-
ly, but only in higher.doses than those necessary to induce 
the functional changes (Goldstein~ al., 1970). 
Single unit recording from dopaminergic areas has 
made it possible to test further and investigate the effect 
of apomorphine. Apomorphine given intravenously in a dose 
of 0.1 mg/kg has been shown to inhibit dopamine unit activi-
ty (Bunney ~ !3-1., l97J). This effect is not influenced by . 
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alpha-methyl-para-tyrosine but is blocked by haloperidol. 
It is therefore possible to explain a decrease in synthesis 
and turnover of dopamine by the concept of a compensatory 
neuronal feedback mechanism {Anden et al., 1969; Carlsson 
and Linquist, 1973). The interruption of' impulse flow .in 
dopamine neurons cause a marked increase in striatal dopa-
mine {Walters et al., 1973) an effect that can be blocked 
by apomorphine {Anden ~ al.,1973). This finding suggests 
that dopamine neurons are at least partly autoregulatory. 
Released or extraneuronal dopamine seems to act on presynap-
tic inhibitory dopamine receptors. Stimulation of the in-
hibitory dopamine receptors on dopamine neurons, either by 
dopamine or apomorphine, may inhibit both nerve activity 
and dopamine synthesis (Christiansen and Squire~, 1974). 
The systemic administration of apomorphine produces 
stereotyped behavior in rats which is characterized by con-
tinuous and compulsive sniffing, licking and gnawing {Ernst, 
1965). The results of several studies have supported the 
hypothesis that stereotyped behavior induced by apomorphine 
is due to increased dopamine receptor activity {Ernst, 1969; 
Fuxe and 'Ungerstedt, 1969). 
produce hypothemia in mice. 
Apomorphine has been shown to 
This hypothemic effect is an-
tagonized by haloperidol and pimozide, indicating that 
dopaminergic mechanisms are involved in temperature control 
{Fuxe and Sjoqrist, 1972). In a number of rats apomorphine 
consistently facilitated sel f - st imulation but inhibited 
this behavior in others {Broekkamp and van Rossum, 1974). 
These results indicate that apornorphine is able to replace 
the reinforcing action of intracranial rewarding stimula-
tion. 
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G. Neuroanatomical Pathways Related to Morphine Dependence 
and Abstinence 
Physical dependence on morphine is characterized by 
the appearance of abstinence signs when morphine intake is 
abruptly terminated or when an opioid antagonist is admin-
istered. The specific action of morphine and its surrogat·es 
on the central nervous system suggest the presence of neuro~ 
anatomical pathways which are selectively sensitive to opoid 
compounds. 
The neuroanatomical sites of morphine action have been 
the subject of many investigations. Lotti et al. (1965) 
demonstrated that the hypothnrmic effect of morphi.ne could 
be induced when morphine was applied locally to the anteri-
or hypothalainus. Injection of' 50 ug of morphine sulfate in 
to the region of the preoptic anterior hypothalamic nuclei 
led to a fall in core temperature while injections into 
other regions of the hypothalamus were ineffective. Intro-
duction of the drug into the area of the mammallary nuclei 
caused hyperactivity and hyperthermia. It was suggested 
that the hypothermic effect -of morphine is due to a depres-
sion of the set point of the hypothalamic thermostat, 
possibly by rendering the cells insensitive to the stimulus 
of the input from the cold receptors in the skin. Tsou 
and Jang (1964) also using the technique of intracerebral 
microinjections, localized the site of the analgesic ac-
tion of morphine in the rabbit to the periventricular gray 
of the third ventricle. Analgesia has also been reported 
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by Herz et al. (1970) after application onto the surface of 
the fourth ventricle and Buxbaum tl al. (1970) after appli-
cation into the anterior nuclei of the rat thalamus. Nalox-
one has been found to reverse morphine analgesia in the 
medial thalomic nuclei and in medial portions of the mid-
brain (Collins tl al.·, 1974). These results tend to indi-
cate that medial mesodiencephalic areas of the brain are in-
valved in morphine analgesia. The caudate nuclei has also 
been implicated as important in mediating the altered reac-
tion to pain induced by morphine (Glick, 1974). Bilateral 
lesions of the caudate nuclei were shown to produce a per-
sistent potentiation if the effect of morphine on ~scape 
luten_cies (Glick, 1974). These studies indicate that al-
though the opioid molecule may act on a common biochemical 
element in different tissues, the amount and the coupling 
of the biochemical element of specific tissue functions de-
termine the specificity of opioid actions. 
The central sites related to physical dependence have 
been studied by localized manipulations of brain tissue. 
Wikler (1948, 1952) reported that removal of the cortex in 
dogs did not attenuate the abstinence syndrome but that 
spinal cord sections interfered with some withdrawal signs. 
This work has been confirmed by the demonstration that mor-
phine dependence has a supraspinal and spinal component 
(Martin and Eades, 1964). It has been reported that bilater-
al rostral cingulomotomy markedly attenuates abstinence phe-
nomena after withdrawal of morphine in monkeys and a variety 
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of opioid analgesis in patients with intractable pain. Foltz 
et al., 1957; Wilker (1972) has reported that the salutary 
effects of cingulumotomy on the morphine withdrawal syn-
drome consist largely of attenuation of non-specific (emo-
tional) reaction to the unmodified specific morphine with-
drawal syndrome. Bilateral lesions in the cingulum, the 
dorsalmedial thalamic nucleus, the anterior temporal lobe, 
or the septum do not alter the specific signs of the pri-
mary morphine withdrawal syndrome in the rat (Wilker; 1972). 
No r do . cingulumotomy or lesion in the dorsomedial thalamic 
nucleus, the anterior temporal lobe or the septum prevent 
relapse (Wilker, 1972). Stereotaxic lesions in the ~entro-
medial nucleus suppressed or diminished the autonomic signs 
of withdrawal and produced a marked intolerance to morphine 
. .. 
(Kerr and Pozuelo, 1971}. Subsequent studies carried out 
in monkeys showed that lesions of the hypothalamus, amyg-
d a la and septal nuclei, even if the tolerance for morphine 
and severity of the withdrawal had been modified the lesion 
had little or no effect on the craving for morphine, as the 
animals continued self-injected approximately the same 
amount of' morphine sulfate as they did before receiving 
their lesion (Kerr and Pozuelo, 1971). Lesions placed 
sterotaxically in monkeys in the organs of the nigro-stri-
atal system and the nucleus tegementi ventralis, known to 
be mainly dopaminergic pathways, · abolish craving for mar-
phine and the phenomena of withdrawal, as evidneced, re-
spectively, by lack of bar pressing and by absence of the 
50 
manifestations of withdrawal (Pozuelo and Kerr, 1972). Fur-
ther evidence for the involvement of dopamine pathways in 
morphine abstinence has been shown by Gianutsos et al. (1973, 
l974b). They have found that electrolytic lesioning abolished 
the morphine withdrawal aggression in thirty day abstinent 
rats while lesioning of the medial forebrain bundle was in-
effective in blocking the aggression (Gianutsos et al., 1973, 
l974b). 
A central component to morphine dependence has been 
suggested by the studies by Eidelberg and Barstow (1971) in 
the monkey and by Wantanabe (1971) in the rat showing that 
dependence on morphine can be induced by chronic intracrani-
al applications of chronic intracranial applic a tions of mor-
phine. These investigations also demonstrated that withdraw-
al could be precipitated by administration of opioid antago-
nist into the ventricular fluids. Herz et al. (1972) re-
ported that withdrawal signs were elicited in the morphine 
dependent rabbits after administration of nalorphine into 
the fourth ventricle. Wei et al. (1972, 1973) have found 
that meidal thalamus and areas in the diencephalic~mesen­
cephalic junction are more sensitive than neocortical, 
hippocampal, striatal, hypothalamic and mesencephalic struc-
tures to naloxone precipitated withdrawal. Their investiga-
tion indicates that the medial thalamus and rostral mesenc-
phalic structures are involved in precipitated abstinence 
behaviors - n e oc ort ical, hippocampal, hypothalamic, s_tria tal 
and tegmental are a s of the brain are relatively insensitive 
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to naloxone precipitated withdrawal. The regional applica-
tion of naloxone to the brain to precipitate abstinence signs 
indicates that the site of adaptation to morphine has neuro-
anatomical specificity. Wei concluded from these results 
that medial thalamic nuclei and closely adjacent structures 
may be the primary sites for the development of opioid de-
pendence. The medial thalamus is also believed to play a 
role in tolerance. Morphine sulfate administration results 
in d~astic alterations in brain bioelectrical activity. 
After repeated drug administrations EEG effects disappear 
(Teitelbaum et al., 1974). An intense morphine response was 
seen after the administration of a single dose of morphine 
to tolerant rats with lesions of the medial thalamus. Des-
pite extensive damage to the medial and lateral habernular 
nuclei, the faciculus retroflexus, and dentate gyous, nalox-
one still reversed the effect of morphine (Teitelbaum et al., 
1974). It appears that medial thalamic lesions have little 
effect on precipitated withdrawal while they have a drastic 
effect on sensitivity to morphine in tolerant rats. 
Recently the occurrence of opioid receptor binding 
has been reported - its localization in the nervous tissue 
(Pert and Snyder, 1973). Their studies of the tissue dis-
tribution provide evidence for the locus of the pharmacolog-
ications of opioids. 
curred in the brain. 
The greatest amount · of binding oc-
Within the brain the opioid receptor 
binding revealed the greatest amount of binding in the 
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corpus striatum where binding exceeded that of the cerebral 
cortex more than fourfold. Of the known neurotransmitters 
only dopamine and acetycholine are found in high concentrate 
in the corpus striatum. Other areas to show binding were 
the midbrain cortex, brainstem, and the cerebellum, in that 
order. 
Several studies have taken the approach of lesioning 
discrete brain areas and then administering chronic morphine; 
upon the termination of morphine withdrawl symptoms are re-
corded. It has been found that rats with bilateral lesions 
in the anterior cingulate cortex show less opiate directed 
behavior following passive morphine injections (Trafton and 
Marques 1971, 1974). Less withdrawal induced weight loss 
is seen in rats with posterior medial forebrain bundle le-
sions. These lesioned rats conslime morphine solution much 
more readily than controls (Glicks and Charap, l97J). Glick 
suggests from this data that the addictive and dependence 
properties may have separate mechanisms. 
A characteristic behavior of rats undergoing withdraw-
al from morphine is the appearance of repetitive shaking 
movements of the body. Several investigations have been 
undertaken to study the neuroanatomical pathways related to 
morphine abstinence, i n particular the eff'ects of brain le-
sions on the wet shake behavior of morphine abstinence. 
Wei et ~· has reported that naloxone precipitated shakes 
are generated in neural elements rostral to the inferior 
colliculus and caudal to the fasiculus retoflexus (Wei ~ 
5 J 
al., 1973). The areas in the rat brain where knife cuts 
attenuate the wet shakes reponse to ice water and where 
naloxone precipitated the shaking behavior, bears consider-
able resemblance to the primary motor area for shivering in 
the cat described by Hemingway as "··· in the dorsamedial 
caudal hypothalamus near the third ventricle just ventral 
to the caudal border of the massa . intermedia of the thala-
mus ••• within the reticular substance dorsal to the marrunil-
lary bodies, dorsomedial to the cerebral peduncles, sub-
stantia nigra and subthalainus ••• 11 • 'This evidence of Wei's 
would indicate that the acute and chronic effects of mor-
phine on wet shakes are mediated in the mesodiencephalon 
of' the brain. 
-; 
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H. The Influence of Chemical Denervation on Morphine Physical 
Dependence and Tolerance 
1) 5,6-Dihydroxytryptamine 
Recently it was found that a strongly reducing con-
gener of serotonin, synthesized by Schlossburger and Kuck 
(1960), 5,6-dihydroxytryptamine (5,6-DHT) induces a selective 
chemical destruction of brain 5-HT nerve terminal (Baum-
garten~ al., 1971) thus reducing brain serotonin contents. 
The antinociceptive effect of morphine is not significantly 
changed by 5,6-DHT pretreatment (Blasing, l97J). The intra-
cerebral administration of 5,6-DH'T in the mouse inhibited 
the development of tolerance to and physical dependE-nce on 
morphine induced by morphine pellet implantation (Ho et al., 
1972). 
2) 6-Hydroxydopamine 
Intraventricular administration of 6-hydroxydopamine 
(6-0HDA) markedl y reduces brain catecholamines (Bloom ~ 
al., 1969). Morphine administration one week following in-
traventricular administration of 6-0HDA has been found to 
increase morphine induced analgesia when measured by the 
tail-flick response. 'Die bilateral administration of 6-
0HDA into the medial hypothalamic areas at the level of the 
ventricular or t he dorsomedial hypothalamic nuclei also 
markedly augmented morphine's effect on the tail-flick 
latency. In addition to these neuroanatomical structures, 
when 6-0HDA was injected into the medial forebrain bundle 
morphine effec t on the tail-flick latency was enhanced. 
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Bilateral local administration of 6-0HDA in.to nucleus caudate-
putamen reduced morphine analgesia (Nakamura et al., 197J). 
This data would seem to indicate that 6-0HDA induced deple-
tion of norepinephrine in the hypothalamus potentiates mor-
phine analgesia whereas depletion of dopamine in the caudate 
nucleus _decreases morphine analgesia. 
The involvement of brain dopamine in the morphine an-
tinociceptive effect has also been shown in other studies. 
Rats treated intracisternally at two week~ o1 age with 6-
0HDA which depleted both brain norepinephrine and dopamine 
showed antagonism of morphine antinociception six weeks la-
ter when measured by the hot-·plate and tail-flick tests. 
Preferential depletion of brain dopamine by desinethylimi-
pramine and 6-0HDA in these rats produced greater antago-
nism of morphine antinociception in the tail-fl.ick test and 
complete antagonism in the hot-plate test (Elchisak et al., 
1973 ) . A reduced analgesic response to morphine has been 
found in both tolerant and nontolerant mice after the intra-
cerebral administration of 6-0HDA without modifying the · 
brain uptake of morphine (Friedler et al., 1972). A de-
crease in sensitivity to morphine has also been reported 
for tolerant and nontolerant rats following pretreatment by 
6-0HDA (Bhargava ~al., 197J). 
The morphine dependent state has also been found to be 
altered by 6-0HDA. Precipitated abstinence, measured by 
naloxone indu~ed withdrawal jumping in mice was enhanced by 
6-0HDA pretreatment; weight loss after abrupt withdrawal was 
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also increased by 6-0HDA (Friedler et al., 1972). Intra-
ventricular injection of 6-0HDA has been found to exacerbate 
morphine withdrawal in the rat (Bhargava et al., 1973). 
The intraventricuJ_ar administration of 6 -0HDA caused 
a marked depletion of brain-norepinephrine in saline treated 
rats and in rats treated either chronically or with a single 
dose of morphine. The increase in brain dopamine seen 
twenty-four hours after the administration of 6-0HDA to con-
trol rats ·was not observed when 6-0HDA was administered to 
rats previously treated with morphine - a decrease in brain 
dopamine was observed in these rats. One week after treat-
meni, with 6-0HDA both brain noradrenaline and morphine con-
cen~rations markedly decreased. While chronic morphine treat -
ment with morphine caused no significant effect on the de -
pletion of brain norepinephrine after 6-0HDA, chronic treat-
ment with morphine did inhibit the depletion of brain dopa-
mine (Nakamura e t al., 1972). These results are interpreted 
to suggest that chronic treatment with morphine may induce 
changes in the uptake process of the nigrostriatal system. 
III. GENERAL METHODS AND MATERIALS 
A. Animals 
Male hooded rats of the Long-Evans strain, r~ndom-bred, 
weighing 250-400 grams were obtained from Charles River 
Breeding Farms, Wilmington, Massachusetts. Prior to their 
use in this investigation the rats were housed in individual 
cages and allowed free access to food and water ·at all times. 
B. Drugs 
Haloperidol (Haldol) was obtained through the courtesy 
of McNeil Laboratories, Inc.,Fort Washington, Pennsylvania 
and Janssen Pharmaceutica, Beerse, Belgium. Morphine suJ. -
fate and apomorphine hydrochloride were obtained from the 
Mallinckrodt Chemical Works, St. Louis, Missouri. The dl-
alpha-methyl -para- tyrosine was obtained from Regis Chemical 
Company , Chicago, Illinois. 
Haloperidol was dissolved in O.J% tartaric acid. Mor-
phine sulfate and apomorphine hydrochloride were dissolved 
in distilled water. Alpha-methyl-para-tyrosine was sus-
pended in 0.5% carboxyrnethylcellulose. 
C. Brain Lesions 
Under ether anesthesia, bilateral electrolyi;ic lesions 
were made with a monopolar stainless steel electrode with 
a 0.5 mm non-insulated tip. A current of either 2mA for J O 
seconds· duration or lmA for 15 seconds duration generated 
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by a Lesion Producing Device (Stoelting Co. Model 58040, 
Chicago, Ill.) was passed through the · electrode placed into 
the brain with a David Kopf Stereotaxic instrument. With 
the dorsal cranium horizontal, the coordinates for the nigro-
striatal bundle were l.5 mm posterior to bregma, 2.0 mm 
lateral to the midline suture and 8. 5 nun below the surface 
of the cranium. Lesions of the medial forebrain bundle were 
placed 2.0 mm posterior to bregma, l.5 mm lateral to the 
midline suture and 8.5 mm below the surface of the cranium 
in a horizontal position. 
D. Drug Administration 
Rats were made depende::.~t upon morphine by injecting 
them intraperitoneally with systematically increasing doses 
of morphine sulfate three times a day. The starting d ose of 
15 mg/kg/injection was increased by 15 mg/kg every day until 
a dose of 405 mg/kg/day was reached. In those rats who re-
ceived a terminal dose of 200 mg/kg only two in j ections & 
day were given 12 hours apart. The starting dose of 10 mg/ 
kg/injection was increased by 10 mg/kg every day until a 
dose of 200 mg/kg was reached. They were maintained at this 
dose for at least five days before using them in withdrawal 
studies. 
In the investigation of recovery from nigro-striatal 
lesions, haloperidol, morphine sulfate and alpha-methyl-
para-tyrosine were administered intraperitoneally twice a 
day for a three or six day period with the last injection 
being given 24 hours prior to surgery. 
·~ --~-~------
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E. Measurement of Withdrawal Symptoms 
Abstinence symptoms were measured after the aburpt ter-
mination of chronic morphine administration and the lesioning 
of various brain regions. Symptoms were measured once every 
24 hours for the first 72 hours after the withdrawal of mor-
phine and/or brain lesioning. In addition to these initial 
observations the occurrence of withdrawal symptoms in brain 
lesioned subjects was measured three weeks following the pro-
duction of the lesion. The rats were removed from their home 
cages and placed individually into a novel cage. Symptoms 
were measured for JO minutes. Prior to these observations 
the rats were weighed and their rectal temperature taken 
(Martin et al ., 196J). The abnormal behaviors noted during 
the observation period consisted of wet shakes (Martin et 
al., 196J), writhing (Bucket, 1964), ptosis and piloerec-
tion {Wikler, 1960). Aggression (Lal et al ., 1971) was mea~ 
sured seventy-two hours after the last morphine injection. 
Violent shaking movements of the head and/or body of the rat 
which resemble the action of an animal which has been 
drenched with water are defined as wet shakes and the rate 
. of occurrence for the observation period is recorded. Writh-
ing consists of dragging of the abdomen along the floor of 
the cage and drawing in of the abdominal wall {Buckett, 1964) 
or arching of the back, neither of which is accompanied by 
yawning. The number of wriths occurring during the JO min-
ute observation period was noted. The presence or absence of 
piloerection, the condition in which the animal's fur stands 
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on end, more than a 45~ angl~ is noted during the period of 
observation. Ptosis is defined as the condition where the 
rat's eyelids are drooping, the eye thus appears as slit-
like. The length of time during the observation period that 
the rat was exhibiting ptosis is measured. The reduction 
of body temperature during morphine abstinence, hypothermia, 
was measured using a digital thermister thermometer (Digitec 
Model 8500-J United Systems, Corporation). The rectal probe 
was inserted Scm and maintained in place for one minute be-
fore recording the temperature. The extent of hypothermia 
was calculated from the body temperature one hour after the 
last morphine injection or the period just prior to produc-
tion of the lesion. The change in body weight during ab-
stinence and/or after brain lesions is calculated from the 
body weight after the last injection of morphine and/or the 
production of the brain lesion. To measure aggressive re-
sponses the rats were aggregated in groups of four 72 hours 
after the last morphine sulfate injection. The aggression 
was measured as duration of rearing (in seconds), number of 
vocalizations and the number of attacks and bites. Attacks, 
including bites . and rearing, were recorded by the experi-
menter. Vocalizations w-ere recorded automatically through 
an Audio Threshold relay. 
F. Histology 
Representative animals from the various drug-treated 
and saline control groups were used to evaluate the site of 
lesioning. Those subjects chosen for evaluation were per-
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fused with Dietrick 1 s Fixative at the conclusion of the ex-
periment. Dietrick's Fixative was prepared by combining 
1800 ml of water, 90 ml of 95% ethyl alcohol; JOO ml of 40% 
formaldehyde and 60 ml of glacial acetic acid. The brain 
was then removed from the cranium and allowed to harden in 
Dietrick's Fixative. After the brain tissue had hardened 
for at least 24 hours, it was then washed in water for sever-
al hours. Increasing concentrations of ethanol were used 
to dehydrate the tissue prior to cleansing with chloroform. 
When each brain was embedded in paraffin, 10 micron sections 
were taken from the area containing the lesion site. The 
sections were then mounted on slides and stained with 
Harris' hematoxglin and eosin according to the method of 
Luna (1968). 
1) Physical Characteristics of the Brain Lesion 
The typical localization of the nigro-striatal lesion 
employed in these experiments based on examination of histo-
logical material from a representative animal is shown in 
Figure 1. Examination of these sections showed the lesion 
to be localized in the area of the lateral hypothalamus, 
with destruction of the nigro-striatal pathway and some 
portions of the medial forebrain bundle. 
When a current of lmA for 15 seconds was employed 
microscopic examination showed the lesion to have destroyed 
an area of O.JO .±. O.OJ mm in diameter; this is a mean of 
four representative subjects. The area destroyed . by this 
lesion is shown in Figure 2. Increasing the current and 
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duration to 2mA for JO seconds produced a greater destruc-
tion of brain tissues. The mean lesion diameter was increased 
to o.47 + O.Ol nun when measured in four.animals. 
destroyed by this lesion is shown in Figure J. 
The area 
In those experiments where the lesion was directed at 
the medial forebrain bundle microscopic examination showed 
the damage to be localized to this area. In some cases some 
slight damage to the immediately adjacent nigro-striatal fi-
bers cannot be ruled out. 
2) Neurochemical Effects of the Lesion 
In order to further confirm the site of the lesion to 
the nigro-striatal dopamine neuron system the dopamine con-
centration in the corpus striatum was determined spectro-
fluorometrically following either a lmA 15 second or 2mA JO 
second brain lesion. 
To evaluate dopamine levels after nigro-striatal le-
sioning the animals were starved for 18-24 hours prior to 
being sacrificed by decapitation. The brains were rapidly 
removed from the cranium and the two cerebral hemispheres 
separated. The lateral ventricle vas opened to expose the 
corpus striatum which was then removed. All of these manip-
ulations were carried out on ice and with ice-cold surgical 
equipment. Striata obtained from lesioned and non-lesioned 
subjects were separately weighed and then homogenized in 
J ml of 0.4 N perchloric acid containing 0.05% sodium meta-
bisulfite. The homogenate was then transferred into a 
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centrifuge tube. The ,homogenizer was rinsed with l ml per-
chloric · acid solution which was added to the homogenate. The 
homogenate samples were then centrifuged at 10,000 RPM for · 
lO minutes in a Servall RC 2B refrigerated centrifuge. 
The supernatant from each centrifuge tube was trans-
ferred into a large centrifuge tube to which 10 ml of 0.5 M 
tris buffer (pH 9.5) was added. The resultant pH of the 
sample was 8.5 ± 0.1. The samples were then poured onto alu-
mina columns and allowed to pass -through at a rate of JO 
drops per minute. After the solution had run through the 
alumina column 5 ml cif deionized glass distilled water was 
added to the large centrifuge tube which was then passed 
through the column. The eluate collected was discarded. The 
dopamine from the alumina column was then extracted by 4 ml 
of 0.2 N acetic acid. The acetic acid eluate was collected 
in a graduated centrifuging tube containing 1 ml of EDTA-
reagent. A two and a half ml sample from each test tube was 
used for the dopamine determination. The two and a half ml 
sample of 0.2 N acetic acid eluate was transferred into an-
other test tube and tci it 0.2 ml of iod~ne solution was added. 
Each test tube was shaken in a Vortex Gemie test tube shaken 
for l5 seconds and after exactly J minutes, 0.2 ml of alkaline 
sulfite was added. The tissue blanks were obtained by the 
residual 0.2 N acetic acid eluate. The tissue blanks were 
prepared by reversing the addition of iodine and alkaline sul-
fite solution. Exactly J minutes after the addition of al-
kaline sulfite solution 0.2 ml of 5 N acetic acid solution 
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was added to each test tube. Again each te~t tube was shaken 
for 15 seconds, placed into a bath of boiling water for 5 
minutes and then cooled to room temperature. The concentra-
tion of dopamine was estimated by reading the samples at 
370 NM while activated at J20 NM on the Amico-Bowman spectra-
fluorometer. The reagent blank consisted of all the re-
agents but dopamine. The concentration of dopamine in the 
experimental samples was determined by comparing the fluores-
cence with the known concentration of a standard dopamine 
solution. The calculated concentration of dopamine was then 
expressed as micrograms of dopamine per gram of wet tissue. 
Twenty-four hours following the lmA 15 second lesion 
there was a non-significant increase in the corpus striatal 
dopamine levels. The average dopamine concentration of the 
corpus striatum in non-lesioned rats was 8.63 + o.49 ug/g. 
At both four and seven days following this lesion, corpus 
striatal dopamine levels were significantly decreased, 
Student's 't' test (pL0.05). The decrease in dopamine 
levels was greatest on the seventh post-lesion day. 
results are summarized in Figure 4. 
These 
Striatal dopamine levels were seen to significantly 
increase, Student's 't' test (p.t'. 0.05) , when more extensive 
nigro-striatal lesions, 2mA for JO seconds, were made 
twenty-four hours prior to measurement.. The corpus striatal· 
dopamine concentration was fou....'1.d to be 6.Jl ± o.40 ug/g in 
non-lesioned controls. Four days after lesioning there was 
a dramatic and significant Student's 't' test (pLo.05), de-
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crease in the concentration of striatal dopamine. The 
levels of striatal dopamine seven days foll-0wing this large 
lesion were not measured due to the death , of all experimental 
animals. These changes in dopamine levels are shown in 
Figure 4. The results achieved here correspond well with 
those of other i nvestigators (Faull et al., 1969; Anden, e .t 
al., 1972; Agid et al., 1974). 
G. Statistical Analysis 
An analysis of variance for repeated measures was used 
to test for significant differences between treated and 
control conditions in the nigro-striatal lesion induced 
weight loss experiments. 
The two-tailed Student's 't' test for independent means 
was used to test for the differences between the means of 
-lesioned and non-lesioned groups in the morphine withdrawal 
experiments. The level of significance was chosen to be 
p L0.05 for rejection of the null hypothesis. 
The results obtained from the effect of drugs pre-
treatment on survival after extensive ni-g ro-striatal lesions 
was analyzed by the Chi-Square test. 
FIGURE l. Typical Cross Section of Rat Brain Showing 
Nig~o-Striatal Ue~tru6tion. 
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FIGURE 2. Representative Small Nigro-Striatal Lesion 
Superimposed on a Figure From the Konig 
and Klippel Atlas (1963). 
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FIGURE J. Representative Large Nigro-Striatal Lesions 
Superimposed on a Figure From the Konig and 
Klippel Atlas (1963). 
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FIGURE 4. Striatal Dopamine Levels at Various Time In-
tervals Following Bilateral Lesions of the 
Nigro-Striatal Pathway Expressed as Percent 
of Non-Lesioned Controls. Dopamine Levels 
Were Measured at l (N=9), 4 (N=ll) and 7 (N=8) 
Days Following 15 Sec lmA Current Lesions and 
at l (N=8) and 4 (N=8) Days After J O sec 2rnA 
Current Lesions. Control Dopamine Levels are 
Given in the Text. 
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DAYS AFTER 
NIGRO-STRIATAL 
LESIONING 
IV. EFFECT OF HALOPERIDOL, METHYL-PARA-TYROSINE 
AND MORPHINE ON WEIGHT LOSS AND LETHALITY 
DUE TO NIGRO-STRIATAL LESIONS 
A. Introduction 
Bilateral lesions of the lateral hypothalamus produce 
a complete cessation of eating and drinking (aphagia and adip-
sia) eventually leading to death in spite of ample food and 
water availability (Anand and Brobeck, 1951). Although ex-
tensive information has been accumulated on the changes in 
food and water regulation following LH lesions, knowledge 
about anatomical structures is still incomplete. Several 
newer experiments have questioned the role of the LH as a 
"feeding center," and several studies have Sliggested that 
the critical areas for producing aphagia and adipsia may be 
outside or include only a far lateral segment of the later-
al hypothalamus (Morgane, 1961; Gold, 1961; Grossman and 
Grossman, 1971; Wampler, 1971). These critical areas in-
clude portions of the globus pallidus, the medial portion 
of the internal capsule, and a small portion of the lateral 
hypothalamus area adjacent to the internal capsule. Sever-
al fiber systems pass through these areas and are known to 
regulate the content of norepinephrine, dopamine and sero-
tonin in the telencephalon. 
One such fiber system, the nigro-striatal bundle (NSB), 
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regulates the dopamine content of the neostriatum (the cau-
date and putamen). Nigrofugal fibers · pass through areas de-
scribed as critical for producing the LR .syndrome. Rats 
sutaining a complete electrolytic (Oltsman and Harvey, 
1972) lesion of the NSB or chemic a l lesion (Ungerstedt, 1970, 
1971) of the NSB show a severe aphagia and adipsia resulting 
in death, unless the animals are force-fed. 
When animals that have received lateral hypothalamus 
lesions are force-fed they gradually recover from their feed-
ing deficits (Teitelbaum and Epstein, 1962). The basis of 
recovery after lateral hypothalamic lesioning is not known 
des:")ite much investigation. A denervation supersensitivity 
model may be useful in explaining recovery (Sharpless, 1 964 ). 
If a supersensitivity phenomenon were the factor responsible 
for the recovery of food regulating behavior, then certain 
results could be predicted; namely, neurons which were made 
supersensitive at some time prior to destruction of the NSB 
could then be expected to facilitate recovery. 
Administration of alpha-methyl-para-tyrosine (MPT), a 
known blocker of catecholamine synthesis (Nagatsu et al., 
1964) will produce a partial denervation of catecholamine 
pathways (Tarsy and Baldessarini, 1973). Recent research 
has shown that pret reatment with MPT before lesioning of the 
lateral hypothalamus facilitates recovery from the syndrome 
(Glick et al., 1972). However, MPT blocks the synthesis of 
all the catecholamines, and further, the lesion used by 
Glick et al. (1972) was located in the lateral hypothalamus; 
thus, their results do not distinguish between noradrenergic 
and dopaminergic e ffects .either pharmacologically or neuro-
anatomically. The issue is especially significant since 
the suggestion has been made that reccvery of nutritive reg-
ulation after lateral hypothalamus lesioning is dependent 
upon recovery within a noradrenergic reward system {Berger 
et al., 1971, 197J). 
This experiment was undertaken to establish the role 
of dopaminergic neurons in the regulation of body weight. 
· Both partial (lmA 15 sec) and extensive (2mA JO sec ) nigro-
striatal lesions will be produced and post lesion recovery 
studied. Rats were injected with either saline, haloperidol 
or alpha-methyl-para-tyrosine for three days prior to the 
production of partial {lmA 15 sec ) nigro-striatal lesions. 
Alpha-methyl-para-tyrosine pretreatment were employed since 
previous reports indicated that it facilitated recovery from 
lateral hypothalamic lesions. Haloper~dol served to dis-
tinguish between dopaminergic and adrenergic mechanisms in 
recovery. Following lesioning animals were observed daily 
for changes in b ody weigh~. Drug treated groups were com-
pared with salin e controls to determine if drug pre-treat-
ment effected weight changes follo wing nigro-striatal lesion-
ing. Prior to extensive {2mA JO sec ) lesioning of the 
nigro-striatal t ract either saline, haloperidol or morphine 
were administered for a six day period. Since pre vious 
evidence suggest ed that acute morphine blocks dopamine re-
ceptors it was t hus incorporated to test the role of 
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dopaminergic supersensitivity in post lesion recovery. These 
drug treated animals were compared to saline treated controls 
with respect to lesion induced weight changes and lethality. 
It was hypothesized that lesioning of the nigro-striatal 
tract would result in aphagia and ad-ipsia as indicated by a 
loss of body weight. Drugs which reduce dopaminergic recep- . 
tor activity are hypothesized to facilitate recovery from 
lesion induced weight loss, thus establishing a role for 
brain dopaminergic systems in the regulation of body weight. 
B. Method 
Haloperidol (o.4 mg/kg), methyl-para-tyrosine (50 mg/ 
kg) or saline were administered intraperitoneally (i.p.) 
twice a day (8 a.m. and 8 p.m.) for three consecutive days 
with the last injection given 24 hours prior to the produc-
tion of a partial (lmA 15 sec ) bilateral nigro-striatal 
lesion. A six-day pretreatment period of morphine (30 mg/ 
kg),haloperidol (2 mg/kg) or s a line, injected t wice daily 
was given prior to the production of an extensive (2mA J O 
sec ) bilateral nigro-striatal lesion. 
was given 24 hours before surgery. 
The last injection 
Throughout the experiment the rats were house:l individ-
ually and given free a ccess to dry food and water. Force 
feeding was not attempted. Body weights were taken daily 
during both pre- and post- lesion periods. The occurrence 
of a death in either the experimental or contr~l groups was 
recorded. A represent ative group of surviving rats were 
sacrificed 16 days after the production of the lesion and 
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the lesion si .te determined by histological procedures as de-
scribed in Chapter III. 
C. · Results 
Those animals receiving partial (lmA 1.5 sec ) nigro-
striatal lesions continued to lose body weight until the 
fifth post-operative day as can be seen from Table 1. Ana-
lysis of variance for repeated measures (Winer, 1962) showed 
that tho~e groups pretreated with alpha-methyl-para-tyrosine 
or haloperidol lost significantly (p L 0.05) less body weight 
than did saline controls. The extent of total weight loss 
was diminished in these drug treated animals as evidenced by 
their higher percentage body weights as compared to saline 
treated controls. These re3ults are shown in Figure 4. The 
saline treated controls showed a greater loss in gram of 
body weight indicating that the drug treated group began to 
recover earlier. These results are SLurunarized in Figure 5. 
When a current of 2mA for a JO second duration was em-
ployed to make a more extensive lesion of the nigro-striatal 
tract the resulting aphagia and adipsia produced death in 
all saline treated controls. These results are shown in 
Table 2. All of the rats in the control group died within 
two weeks of the lesion, -nearly half of them in less than 
eight days. Percentage body weight changes were similar 
for both treated and control groups for the first six post-
lesion days as can be seen in Figure 6. From the 9th to the 
14th post-operative day, the saline treated rats showed a 
greater loss in grams of body weight than did the groups 
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Table l. Weight Changes1 Following Small Lesions 2 of the 
Nigro-Striatal Bundle with Pretreatment by Halo-
peridol3 or Alpha-Methyl-Para-Tyrosine4-6 
Treatment 
Postoperative Saline Haloperidol Methyl-p-Day (N=8) N=8) N=5) 
1 89.8 + o.4 93.4 + 1.4 91.6 + 1.6 
2 85.3 ±. 0.9 92.0 + 1.6 88.2 + 2.8 
3 83.7 ±. 1.1 90.0 + 1.3 87.6 + 3.6 
4 83.6 + 2.0 88.8 ±. 2.2 86.4 + 3.9 
5 84.1 + 2.7 90.7 + 1.5 89.2 + 5.1 
6 86.5 + 2.6 91.8 ±. l.J 91.0 + 4.9 
7 86.4 + 2.9 93.3 + 1.4 90.2 + 4.9 
1. Weights are expressed as means and standard errors of 
percent weight relative to preoperative weight. Num-
ber of subjects per condition is indicated in parenthe-
ses. 
2. Each subject was lesioned bilaterally using 1 mA for 
15 sec. 
3. 0.8 mg/kg/day was administered i.p. for 3 days. 
4. 100 mg/kg/day was administered i.p. for 3 days. 
5. An analysis of variance for repeated measures14 com-
paring the haloperidol and control conditions on days 
2 through 7 indicated a significance (F=7.6, p L.05 for 
df = 1, 14). 
6. Preoperative weights were J67.8 .±. 6.5, 318.4 ±. 19.1, 
371.5 ±. 9.2 grams respectively for saline, haloperidol 
and methyl-p-tyrosine treated groups. 
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Table 2. Weight Changes1 Following Large Lesions 2 of the 
Nigro-Striatal Bundle With Pretreatment by Mor-
phine3 or Haloperidol4-5 
Postoperative 
Day 
Treatment 
l 
2 
J 
4 
5 
6 
7 
8 
9 
10 
ll 
12 
lJ 
14 
Saline 
87.l+l.J (ll) 
80.4+1.l (ll) 
74.7±1.l (11) 
70.9±1.0 (ll) 
67.0+l.l (ll) 
6J.O±l.4 (10) 
60.7±1.8 ( 7) 
60.6±2.J ( 4) 
54.5±3·5 ( 2) 
51.0±2.8 ( 2) 
48.0±l.4 ( 2) 
46.0+0.0 ( l) 
44.o+o.o ( l) 
( o) 
Morphine 
88.4+0.6 (15) 
81.7+0.6 (15) 
76.8+0.7 (15) 
7J.0+0.8 (15) 
69.4+0.9 (15) 
66.2+0.7 (15) 
6J.9.±.l.4 (lJ) 
65.J.±.2.8 (10) 
69.7+4.2 ( 7) 
75 .0+4.5 ( 6) 
75.8.±.5.l ( 6) 
76.1.±.5·6 ( 6) 
76.8.±.6.4 ( 6) 
78.4.±6.8 ( 6) 
Haloperidol · 
89.J+l.2 (28) 
8J.O.±.l.l (28) 
77.6+l.l (27) 
7L~.l.±l.2 (25) 
70.0±1.4 (25) 
68.7±1.6 (24) 
67.1±2.0 (21) 
67.2.±.2.7 (16) 
70.9+3.5 (12) 
70.5+4.2 (11) 
76.0.±5.6 ( 8) 
77.8.±7-1 ( 7) 
90.3+7.8 ( 6) 
9l.4.±4.4 ( 5) 
l. Weights are expressed as means and standard errors of 
percent weight relative to preoperative weight. Num-
ber of subjects per condition is indicated in paren-
theses. 
2. Each subject was lesioned bilaterally using 2 mA for 
JO sec. 
J. 60 mg/kg/day of morphine sulfate was given i.p. for 6 
days. 
4. 
5. 
4 mg/kg/day of haloperidol was given i.p. for 6 days. 
Preoperative weights were Jl6.8+2J.J, J65.4+10.7, 
JJ0.7.±7.4 grams respectively fo; saline, morphine and 
haloperidol treated groups. 
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pretreated with haloperidol (4 mg/kg/day) or morphine sul-
fate (60 mg/kg/day). These results are summarized in Figure 
7. A significantly greater number of rats pretreated with 
morphine or haloperidol were still alive on the 15th post-
operative day when compared to saline treated controls (mor-
phine vs saline p L 0. 001 and haloperidol vs saline p L o. Ol 
by the Chi-Square test). These data are shown in Figure 8. 
D. Discussion 
Tne extent of weight loss in the lesioned animals was 
dependent upon the amount of nigro-striatal damage. These 
results support previous suggestions (Oltsman and Harvey, 
1972; Ungerstedt, 1970, 1971) that the destruction of the 
riigro-striatal pathway is critical fcir the production of 
the lateral hypothalamic syndrome. Facilitations of recovery 
f'rom the syndrome produced by large lateral hypothalamic 
lesions has previously been demonstrated with methyl-para-
tyrosine treatment (Glick et al., 1972), and the present 
results show an analogous effect of methyl-para-tyrosine 
on recovery from nigro-striatal damage of a less extensive 
area. Recovery was also facilitated by pretreatment with 
haloperidol. Lethality from massive nigro-striatal damage 
was reduced if subjects were treated with haloperidol" or 
morphine for a six-day period prior to surgery. 
A definite mechanism underlying recovery from the de-
struction of the nigro-striatal pathway cannot as yet be 
proposed. Several suggestions are worthy of ~onsideration, 
first an increase in sensitivity of postsynaptic receptors 
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(Cannon and Rosenbleuth, 1949; Stovraky, 1961; Glick et al., 
1972); s~condly the reg enera tive sprouting from transected 
axons (Katzman e t a l., 1971; Nygren e t al., 1971); third and 
lastly is an increase in catecholamine turnover in surviv-
ing neurons (Bloom et al., 1969; Uretsky et al., 1971; Agid 
et al., l97J). Any or all of these changes are likely to 
promote recovery. All the drugs found active in promoting 
recovery have one property in common, that is, they produ.ce 
dopamine deficiency at receptor sites. Alpha-methyl-para-
tyrosine is a well-knoi.m i;nhibitor of catecholamine syn-
thesis (Nagatsu et al.; 1964) haloperidol blocks dopamine 
receptors directly (Janssen, 1967; Van Rosswn, 1967; Anden 
et al., 1970) and morphine blocks dopamine receptors indi-
rectly, possibly through an effect on non-dopaminergic 
neurons - (Puri et al., l97J). The other pharmacological 
effects of the drugs employed in this study are not common 
to all three drugs. 
A drug induced deficiency of receptor activity can 
cause both an increase in receptor sensitivity as a con-
sequence of pha rmacological denervation (Sharpless, 1964) 
and stimulate n e uronal feedback mechanism (Fuxe and 
Ungerstedt, 197 0). Chronic treatment with haloperidol 
(Gianutsos et a l., l974a, 1975), methyl-para- t yrosine 
(Tarsy and Baldessareni, 1973), and morphine sulfate (Puri 
and Lal, 1973 ) is known to cause supersensitivity of dop-
amine receptors in the central nervous system. Both 
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haloperidol and morphine sulfate increase dopamine synthe-
sis in the nigro-striatal system (Janssen, 1967; Gunne 
et al., 1969; Puri~ al., 1973). The pretreatment with 
these drugs, that increase neurotransmitter synthesis, 
could promote the development of a compensatory change in 
the level of activity of the surviving dopamine contain-
ing neurons (Bloom et al., 1969; Uretsky et al., 1971; 
Agid et al., 1973). The stimulation of neurotransmitter 
synthesis could possibly accompany stimulation of several 
other processes which play a part in the regenerative 
process, which, of the suggested effects of these drugs 
under consideration might actually account for the .:>bserved 
promotion of recovery after nerve injury needs further in-
ve'stigation. 
V. MODIFICATION OF NARCOTIC WITHDRAWAL SYMPTONS 
BY NIGRO-STRIATAL AND MEDIAL FORE 
BRAIN BUNDLE LESIONS 
A. Introduction 
The participation of dopaminergic neuronal systems in 
narcotic dependence and wj_ thdrawal has been suggested in re-
cent years by several lines of evidence. Morphine with-
drawal aggression in dependent animals can be selectively 
potentiated by dopam.inergic stimulating agents and blocked 
by drugs which block dopamine receptors (Puri et al., 1971; 
Lal and Puri, 1972; Puri and Lal, 1973). Haloperidol, a drug 
with some specificity for blocking dopamine receptors (Janssen 
1967; Von Rossum, 1967; Anden et al., 1970) has been reported 
--
to reduce morphine withdrawal syndrome in animals and hu-
mans (Lal et al., 1971; Karkalas and Lal, 1972). Haloperidol 
also reduces the self a dministration of morphine in addicted 
rats (Hanson and Cimine-Venema, 1972) and monkeys (Pozuelo 
and Kerr, 1972). Lesions placed stereotaxically in monkeys 
in the origin of the nigro-striatal system and the nucleus 
tegmenti ventralis, known to be mainly dopaminergic path-
ways, abolish craving for morphine and the phenomena of with-
drawal, as evidenced, respectively by lack of bar pressing 
and by lack of withdrawal manifestations (Pozuelo and Kerr, 
1972). Further evidence for the involvement of dopamine 
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pathways in morphine abstinence has been shown by Gianutsos 
et al. (1973,1974). They have found that electrolytic le-
sioning of the nigro-striatal bundle abolished morphine 
withdrawal aggression in thirty-day abstinent rats while le-
sioning of the medial forebrain bundle was ineffective in 
blocking the aggression (Gianutsos et al., 1973, 1974b). 
Further evidence for the interaction between brain 
dopamine and morphine comes from biochemical studies. Acute 
morphine elevates brain homovanillic and 3-4 dihydrophenyl-
acetic acid (:Fukui and Tugaki, 1972; Kuschinsky and Horny-
kiewicz, 1972), increase the synthesis of labeled dopamine 
from labeled tyrosine in the brain (Clouet and Ratner, 1970; 
Fukui et al., 1972; Smith et al., 1970, 1972) and acceler-
ates the disappearance of dopamine after the administration 
of .alpha-methyl-para-tyrosine (Gunne ~al., 1969; Puri et 
al., 1973). These observations strongly suggest the involve-
ment of dopaminergic pathways in morphine action and depend-
ence. 
In order to understand the role of the nigro-striatal 
dopaminergic pathways in morphine dependence, this study in-
vestigated the effect of nigro-striatal lesions produced 
prior to and following the production of dependence on with-
drawal symptoms. Morphine dependence was 
with partial (lmA 15 sec ) nigro-striatal 
produced in rats 
lesions. After 
the abrupt termination of morphine injections narcotic with-
drawal symptoms were compared between lesioned and non-
lesioned groups. Both partial (lmA 15 sec ) and extensive 
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(2mA JO sec ) nigro-striatal lesions were produced during 
the withdrawal period. These lesions were made at both 0 and 
48 hours after the terminal dose of morphine. Withdrawal 
symptoms were measured in lesioned and non-lesioned groups 
and compared. The aforementioned experiments were conducted 
at two different levels of morphine dependence, at terminal 
doses of 200 and 405 mg/kg/day of morphine sulfate. The 
dopaminergic stimulating agent, apomorphine (A..~den ~al., 
1967; Ernst, 1967) was administered to both intact and 
nigro-striatal lesioned morphine withdrawn subjects to fur-
ther assess the role of dopaminergic receptor activity in 
the abstinence phenomena. In order to determine if the re-
sults were specific for the dopaminergic system the medial 
fore brain bundle, a noradrenergic and serotonergic neuron 
system, was also lesioned after the production of dependence 
and abstinence signs observed. It was hypothesized that 
nigro-striatal lesions would modify the withdrawal symptoms 
that involved dopaminergic mechanisms. 
B. Method 
Male hooded rats were housed in individual cages dur-
ing the addiction and withdrawal phases of these experiments. 
Brain lesions were made under anesthesia either prior to or 
following the production of dependence. At the completion 
of each experiment a representative group of animals were 
sacrificed for histological localization of the lesion site. 
Rats were made dependent upon morphine by injecting 
them intraperitoneally with systematically increasing doses 
8() 
of morphine sulfate three times a day. The starting dose of 
15 mg/kg/injection was increased by 15 mg/kg every day until 
a dose of 405 mg/kg was reached. 
In those rats who received a terminal dose of 200 mg/ 
kg orily two injections a day were given twelve hours apart. 
The starting dose of 10 mg/kg/injection was increased by 10 
mg/kg every day until a dose of 200 mg/kg was reached. They 
were maintained at this dose for at least five days after 
which no morphip.e was injected. 
Abstinence symptoms were measured after the abrupt 
termination of chronic morphine administration. Symptoms 
were measured once every 24 hours for the first 72 hours af-
ter morphine withdrawal. The rats were removed from their 
home cages and placed individually into novel cages. Symp-
toms were measured for JO minutes; prior to observation 
rats were weighed and then rectal temperature taken. The ab -
normal behavior noted during the observation period consisted 
of wet shakes, writhing, ptosis and piloerection. Aggression 
in response to social grouping was measured seventy-two 
hours after the last morphine sulfate injection. A more de -
tailed description of these procedures can be found in Chap-
ter III. 
C. Results 
1) Modification of' Narcotic Withdrawal Symptoms by -Nigro-
Striatal Lesioning 
a. Lesions made prior to the production of dependence 
Partial destruction of the nigro-striatal path-
way prior t~ the production of morphine dependence modified 
the intensity of the narcotic withdrawal syndrome. Wet 
shakes and ptosis were seen to significantly (pL0.02) in-
crease when compared to non-lesioned addict e d controls by 
the Student's 't' test at 24 and 48 hours of withdrawal re-
spectively. The Student's 't' test indicated a significant 
(pL0.05) lesion effect on weight loss at 24 and 48 hours of 
withdrawal. Hypothermia was found to be significantly 
(pL0.001) increased over the non-lesioned groups by the 
Student's 't' test at 48 hours of withdrawal. Table J pro-
vides a summary of these results. There was a significant 
reduction in 72 hour morphine withdrawal aggression in the 
animals receiving nigro-stria tal lesions prior to the pro-
duction of dependence. These results are shown in Table 4. 
Replication of this e x periment in which the terminal 
dose of morphine was increased to 405 mg /kg/day yielded 
similar results. Analysis of the data with the Student's 
't' test showed that lesioned subjects showed significantly 
(p L. 0. 001) more wet shakes at 48 and 72 hours of withdrawa l 
than did non-lesioned addicted controls. Writhing was found 
to be significantly (pL'. 0.01) decreased at 72 hours of with-
drawal. At 48 hours of withdrawal lesioned rats showed a 
significant (p L O.Ol) increase in ptosis time and weight 
loss when compared to non-lesion addicted controls by the 
Student's 't' test. Using this same statistical test a 
significant (p L 0. 001) decrease in 24 hours withdrawal hypo-
thermia was found. These results are summarized in Table 
J. Morphine withdrawal aggre ssion measured at 72 hours of 
Table J. Modification of the Narcotic Withdrawal Syndrome by Nigro-Striatal Lesioning1 
Prior to the Production of Morphine Dependence 
Non Addicted Addicted 
10 Symptoms 200 mg/kg/day 405 mg/kg/day 
(Hours of Non- Non- Non-
Withdrawal} Lesioned Lesioned Lesioned Lesioned Lesioned Lesioned 
Wet Shakes 3 . 9 24 0.2±0.1 1. 5±1.1 2 .0.±.0.J 5. L~.±.1. 1 9.1.±.1.J 10.6+2.0 
- 5 48 0.2.±.0.l 0.5+0.2 5.6+0.7 7.8+1.4 6.9+0.9 lJ.6+1.7 
72 0.2±0.1 l.0+0.4 6.1+0.7 7. J +l.6 6.J±0.6 - 5 lJ. 6.±.l. 7 
Writhing 
7 24 O.O+O~O 0.5.±.0.5 0.5+014 o.L~+O.O l.9+0.J7 2.l+0.8 
48 o.o±.o.o 0.2+0.2 l.O+O.L~ 1.4+0.5 2.5+0.4 2.0+0.84 
72 o.o+o.o 0.0±0.0 O.J.±.0.1 1.0.±.0.J - 8 J.2±0.9 0.5.±.0.2 
Piloerection 
{No positive/No observed) 
2L1 0/12 4/L~ 15/15 lJ/lJ 27/27 ll~/16 
48 0/12 2/4 15/15 12/lJ 27/27 16/16 
72 0/12 2/L~ 15/15 lJ/lJ 16/16 14/14 
Ptosis Time 6 24 o.o.±.o.o o.o+o.o 28+21 206±1163 101,±.287 92+4J 
h8 o.o+o.o 0.0,±.0.0 o.o+o.o L~ J8+158 87.-t.308 5J6+1J44 
72 o.o.±.o.o 0.0,±.0.0 0.0±0.0 7l1 +l-11 201+60 227,±.92 
Weight Loss 2 9 24 2.6±0.7 10.J.±.J.OJ 12. 8+.l. 5 11. 0,±.l. 9 4 4.8 - - 25.J,±.2.7 26.5±1.5 J5.9+J.O J4.5+2.5 
72 J0.9,±.2.1 JJ.4+4.4 J2.8,±.J.O J7.5+4.J 
l,O 
p 
Table J - Continued 
Hypothermia 
24 
48 
72 
1. lmA for 15 seconds. 
2. Significantly different 
test (pL0.05). 
J. Significantly different 
test (p L 0. 02) . 
o.1+0.01 
0.2+0.40 
o.o+o.oo 
l.~7+0.06 
1.75+0.07 
1.70+0.08 
1.80+0.09 
..... 5 2.79+0.18 
1.98.±.0.11 
2.05+0.07 
1.88+0.06 
l.J5+0.10 
5 1.59+0.08 
1.90+0.10 
1.64+0.ll 
from non-lesioned addicted controls based on Student's It I 
from non-lesioned addicted controls based on Student's It I 
4. Significantly different from non-lesioned addicted controls based on Student's It I 
test ( p I- 0. 01) • 
5. Significantly different from non-lesioned addicted controls based on Student's It I 
test (pL0.001). 
6. Significantly different from 200 mg/kg/day morphine withdrawal, based on Student's 
It I test (pL0.05). 
Significantly different from 200 mg/kg/day morphine withdrawal, based on Student's 
It I test (ptt:o.02). 
7. 
Significantly differ~nt from 200 mg/kg/day morphine withdrawal, based on Student's 
It I test (pL0.01). 
8. 
Significantly different from 200 rng/l}:g/ day morphine withdrawal, based on Student's 
It I test (p '0. 001 ). 
9. 
10. All data are expressed in terms of means and standard errors unless otherwise in-
dicated. The number of animals employed in each group is indicated as the de-
nominator of the fraction used to express the occurrence of piloerection. Ptosis 
time is expressed in seconds, weight loss in grams and hypothermia in degrees 
centigrade. \0 
..... 
t 
~ 
t; 
·, 
Table 4. Seventy-Two Hours Withdrawal Aggression in Rats Receiving Brain Lesions 
Mean + S.E. 
Treatments N Attacks Rearing Vocalization 
Addicted to 405 mg/kg/day 
Intact Controls 5 J2±.2 J014±.19J 1809±.J61 
Small NSB Lesion 1 Prior to Addiction l JO 1261 527 
Small NSB Lesion 
After Addiction1 l J 286 80 
Large NSB Lesion 
After Addiction2 l 21 J09 Jl9 
Small NSB Lesion 
Af'ter Addiction1 l 14 997 29J 
Large NSB Lesion 
After Addiction2 l 5 56 69 
Addicted to 200 mg/kg/day 
Intact Controls J 9±6 1811±.868 929+4 5Lt. 
Small NSB Lesion 1 Prior to Addiction 2 O+O J5+19 lJ±.24 
Small NSB Lesion 
After Addiction2 2 58.:t.4 26J9+l65 827+44 
Large NSB Lesion 
After Addiction2 2 14±7 292.:t.16 209±.110 
\0 
l. 1 mA 15 s e c 2. 2 mA JO sec !\) 
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withdrawal showed a reduction in rearing and vocalization in 
the lesion addicted groups. 
4. 
These results are shown in Table 
The withdrawal syrnptonl3 exhibited by rats addicted to 
200 and 405 mg/kg/day of morphine were compared by the Stu-
dent's 't' test. Wet shakes were increased in those rats 
withdrawing from 405 mg/kg/day at 24, 48 and 72 hours but 
signi_ficance (pLO.OOl) was achieved only at 24 hours. Writh-
ing in these rats was significantly (pL0.02) increased at 
24, 48 and 72 hours. Ptosis was significantly increased at 
24 (pL 0.05), 48 (pL 0.02) and 72 (pL 0.01) hours of with-
drawal _ in rats withdrawn froM 405 mg/kg/day of morphine as 
compared to those withdrawn from 200 mg/kg/day. Weight loss 
was found to significantly (pL0.001) increase at 24 hours. 
Increased hypothermia was observed in rats withdrawn from 
405 mg/kg/day but this increase failed to achieve signifi-
cance. These results are summarized in Table J. 
b. Lesions made after the production of morphine dependence. 
1. Effect of small nigro-striatal lesions 
Rats made dependent, 200 mg/kg/day terminal dose, 
and lesioned (lmA for 15 sec ) following the last injection 
of morphine showed a general increase in withdrawal intensity. 
Withdrawal wet shakes in the lesioned rats were significantly 
(pL 0.001) increased at 24 and 48 hours of withdrawal when 
compared to their non-lesioned counterparts by the Student's 
't' test. At 72 hours of withdrawal a significantly (pL0.02) 
increased amount of writhing was observed in lesioned subjects. 
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Ptosis time was found to significantly (p L 0. 05) increase in 
nigro-striatal lesioned subjects by the Student's 't' test 
at 24, 48, and 72 hours of withdrawal. When the same sta-
tistical test was employed for the effect of the lesion on 
weight loss it showed the lesion groups to have lost a sig-
nificantly (pL0.001) greater amount of body weight at 24, 
48 and 72 hours of withdrawal than non-lesioned controls. 
The Student's 't' test showed a significant (pL0.05) in-
crease in hypothermia at 72 hours. A significant (p L 0. 05) 
' lesion effect was observed for wet shakes and writhing in 
non-addicted rats. Weight loss was also seen in non-ad-
dieted lesioned rats. These results are summarized in Table 
5. Seventy-two hour morphine withdrawal aggression was ap-
parently increased by the lesion, as showTI in Table 4. 
When the terminal dose of morphine was increased to 
405 mg/kg/day a similar lesion effect was noted. The Stu-
dent's 't' test showed significant increases in wet shakes 
at 24 (pL0.02), 48 (p.Lo.05) and 72 (pL0.001) hours in 
the lesioned groups as compared to the non-lesioned ad-
~-
dieted controls. Writhing was found to be significantly 
(pL0.05) decreased at both 24 and 72 hours of withdrawal 
in the nigro-striatal lesioned groups. Significant (p~ 0.001) 
increases in ptosis time and weight loss were seen in the 
lesion groups when compared to the non-lesioned controls 
by the Student's 't' test. Application of this statistical 
test to withdrawal hypothermia showed a significant (pL0.001) 
decrease at 24 hours and a significant (p£0.0l) increase at 
. . . . 1 
Narcotic Withdrawal Symptoms in Rats With Small Nigro-Striatal Lesions Made Table 5. 
After the Terminal Dose of Morphine Sulfate 
Non-Addicted · 
Symptoms6 
(Hours of Non-
Withdrawal} Lesioned Lesioned 
Wet Shakes 5 24 0.2.±.0.l J.0.±.0.63 
48 0.2+0.1 5.Lt.±.1.94 
72 0.2.±.0.l 2.6.±.0.8 
Writhing J 2L~ o.o+o.o l.6+0.64 
48 0.0.±.0.0 l.5+0.52 
72 o.o+o.o 0.5.±.0.2 
Piloerection 
(No positive/No observed) 
24 
48 
72 
Ptosis Time 
24 
48 
72 
Weight Loss 
24 
48 
72 
0/12 
0/12 
0/12 
o.o.±.o.o 
o.o+o.o 
o.o.±.o.o 
12/21 
6/9 
5/9 
193.±,101 
119.±.119 
33.±33 
31.2+1.7 
J6.9+7.4 
Lt6.8+1.4 
Addicted 
200 mg/kg/day 
Non-
Lesioned Lesioned 
5 2.0+0.J 13. 8+4·. 7 5 
5.6.±.0.7 12.3.±.3·3 
6.1+0.7 7.4.±.2.3 
o.s+o.4 0.7£0.7 
l.o+o.4 1. 6+0. 53 
0. 3±,0 .1 1.6+0.9 
15/15 9/9 
15/15 9/9 
15/15 9/9 
28+21 2 763.±,2192 
o.o.±.o.o 670+2902 
o.o.±.o.o 411.±.205 
2.6+0.7 45.8.±.0.9; 
25.3.±,2.7 68.4.±,2.55 
30.9.±.2.l 82.0.±,3.0 
405 mg/kg/day 
Non-
Lesioned Lesioned 
3 9.1.±.1.3 15.1.±.2·72 
6.9.±.0.9 1 7 • 3.±.5 • 0 5 
6.J.±.0.6 11.J.±3·5 
1.9.±.0.3 2 0.5.±.0.l 
2.5.±.0.4 l.5+0.03 
5.4.±.1.7 o.s.±.o.4 
27/27 12/16 
27/27 
16/16 
15/16 
16/16 
101+28 1768+215 
87+30 1178+175; 
384.±,92 1179.±,193 
12.8+1.5 36.4.±.1.1§ 
26.5+1.5 56.0.±.2.85 
31.8.±,3.0 72.9.±.2.6 
\.0 
VI 
Table 5 - Continued 
·' 
Hypothermia 
24 +0.5±0.1 1.87+0.06 1. 78+0 .13 2.05+0.07 5 1.50+0.0J 
l~8 +O.l+O.l 1.75+0.07 2.40+0.25 1.88+0.06 2.58+0.514 
- 2 1.61+0.15 72 +0.2+0.1 1.70+0.08 J.05+0.40 4.02+0.75 
1. lmA for 15 seconds. 
2. Significantly different from non-lesioned controls based on Student's It I test 
(pLo.05). 
J. Significantly different from non-lesioned controls based on Student's It I test 
(pL0.02). 
4. Significantly different from non-lesioned controls based on Student's It I test 
(pL0.01). 
5. Significantly different from non-lesioned controls based on Student's It I test 
( p .L 0. 001 ) • 
6. All data are expressed in terms of means and standard errors unless otherwise indi-
cated. The number of animals employed in each group is indicated as the denominator 
of the fraction used to express the occurrence of piloerection~ Ptosis time is 
expressed in seconds, weight loss in grams and hypothermia in degrees centigrade • 
• 
\0 
O'\ 
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72 hours. These data are shown in Table 5. · The lesioned 
groups showed significantly less 72 hour morphine withdrawal 
aggression. These data are given in Table 4 . 
2. Effect of large nigro-striatal lesions 
Large nigro-striatal lesions made after the terminal 
dose of morphine in rats dependent upon 200 mg/kg/day re-
sulted in increased ptosis time and weight loss. Analysis 
of these data by the Student's 't' test showed a significant 
(p.L0.001) increase in ptosis time and weight loss at 24, 48 
and 72 hours of withdrawal. Hypothermia in the nigro-stri-
atal lesioned rats showed a significant (pL0.001) increase 
at 72 hours. A significant (p.L.0.05) lesion effect was ob-
served for wet shakes and writhing in non-addicted rats. 
Weight loss was also seen in non-addicted lesioned rats. 
These results are summarized in Table 6. Morphine withdraw-
al aggression was decreased by the lesion as shown in Table 
4. 
A similar lesion effect was seen in rats dependent up -
on 405 mg/kg/day of morphine. Writhing was decreased si~-
nificantly (pL0.05) at 24, 48 and 72 hours in those rats 
receiving extensive nigro-striatal lesions after the pro-
duction of dependence. The Student's 't' showed significant 
(pL.0.001) lesion induced increases in ptosis time and 
weight loss at 24, 48 and 72 hours as compared to non-le~ 
sioned addicted controls. Withdrawal hypothermia signifi-
cantly increased at 48 (pLO.Ol) and 72 (pL0.001) hours as 
compared to non-lesioned counterparts. These results are 
Table 6. Narcotic Withdrawal Symptoms After Large Nigro-Striatal Lesions 1 Following the 
Terminal Dose of Morphine Sulfate 
Non Addict ed Addicted 
Symptoms 6 
200 mg/kg/day 405 mg/kg/day 
(Hours of Non Non Non 
Withdrawal) Lesioned Lesioned Lesioned Lesioned Lesioned Lesioned 
Wet Shakes 
24 0.2+0.1 2.2+0.45 2.0+0.J 5.2+1.9 9.1+1.J 6.1+1.9 
48 0.2+0.1 2.6+0.4~ 5.6+0.7 1J.J+4.4 6.9+0.9 10.5+1.7 
72 0.2+0.1 2.4+0.7 6.1+0.7 8.5+2.4 6.J+0.6 9.1+2.J 
Writhing 
24 4 0.5+0.4 1.8+1.J 2 o.o+o.o l.J+0.44 1.9+0.J o.o+o.o 
48 o.o+o.o 2.J+0.6 l.0+0.4 0.5+0.2 2.5+0.J.i. o.7+0.7 2 
72 o.o+o.o l.J+o.62 O.J+O.l 2.4+1.J 3.2+0.9 o.0+0.02 
Piloerection 
(No positive/No observed) 
2L~/25 15/15 9/9 8/8 21+ 0/12 27/27 
48 0/12 10/10 15/15 9.9 27/27 7/7 
72 0/12 10/10 15/15 7/7 16/16 6/6 
Ptosis Time 
24 o.o+o.o l5J+88 28+21 l25J+l665 101+28 1800+005 
L18 o.o+o.o 231+92 2 O+O 1288+1785 87+JO 1740+605 . 
72 o.o+o.o :355+21J O+O 1511+1765 201+60 l800+oo5 
\0 
(X) 
Table 6 - Continued 
Weight Loss 
24 
J.i.8 
72 
Hypothermia 
24 
48 
72 
1. 2 mA for JO seconds. 
2. Significantly different 
(p.£'0.05). 
J. Significantly different 
( p .L 0. 02). 
4. Significantly different 
(pL0.01). 
5 •· Signifi c a ntly different 
(p L0. 001). 
J0.0+2.1 · 
55.3+5.o 
70.2+6.3 
0.00+0.16 
o.6J+0.4J 
0.27+0.42 
2.6+0.7 
25.3+2.7 
J0.9+2.1 
1.87+0.06 
1.75+0.07 
1.70+0.08 
J7.8+J.5~ 
68.7+5.l 
89.1+5.or 
1.55+0.17 
J.00+0.705 
J.L~5+0.41 
12.8+1.5 
26.0+1.5 
J2.8+J.O 
2.05+0.07 
1.88+0.06 
1.35+0.10 
from non-lesioned controls based on Student's It I 
J6.8+2.25 
54.7+2.25 
69.8+2.25 
2.J8+o.4o4 4.88+1.035 
6.98+1.81 
test 
from non-lesioned controls based on Student's 't' test 
from non-lesioned controls based on Student's It I test 
from non-lesione d controls by the Student's It I test 
6. All d a t a a re expre s sed in terms of means and standard errors unless otherwise indi-
cat e d. The number of animals employed in each group is indicated as the denominator 
of the fr a ction used to express the occurrence of piloerection. Ptosis time is ex~ 
pressed in seconds, weight loss in gra ms and hypothermia in degrees centig r a de. 
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summarized in Table 6. The nigro-striatal °lesioned groups 
exhibited reduced morphine withdrawal aggression. 
data are represented in Table 4. 
c. Lesions made during the withdrawal period. 
l. Effect of small nigro-striatal lesions 
These 
The production of small, lmA l5 sec , lesions of 
the nigro-striatal pathway made at 48 hours after the last 
morphine injection produced an increased occurrence of 72 
hour withdrawal symptoms as shown in Table 7. Wet shakes 
100 
and writhing were significantly (pLO.Ol) increased as com-
pared to non-lesioned controls by the Student's 't' test. 
This same test showed a significant (p~O.OOl) lesion effect 
on ptosis time and weight loss. 
2. Effect of large nigro-striatal lesions 
Large, 2mA JO sec , lesion of the nigro-striatal 
tract produced increases in some withdrawal symptoms. 
These data were analyzed by the Student's 't' test. Signif-
icant (pL0.01) increasES in ptosis time and weight loss were 
seen in lesioned subjects as compared to their non-lesioned 
counterparts. These results are summarized in Table 7. 
d. Modification of narcotic withdrawal symptoms by apo-
morphine 
l. Effect of apomorphine on narcotic withdrawal symp-
toms in the intact dependent rat 
Dependent rats, 405 mg/kg/day of morphine, were ob-
served for the occurrence of •withdrawal symptoms and then 
Table 7. Nigro-Striatal Lesioning at Forty-Eight Hours After the Last Morphine Sulfate 
Injection: Effect on Seventy-Two Hour Withdrawal Symptoms 
Non Addicted 
Non Small 2 Large · Non Sym.etoms 7 Les1oned Lesion Lesion3 Lesioned 
Wet Shakes 0.2+0.1 J.0+0.6 6 2.2+0.4 6.J+0.6 
Writhing o.o+o.o i.6-+"o.64 l.J+0.4 J.2+0.9 
Piloerection 0/12 9/17 24/25 16/16 
(No positive/No observed) 
Ptosis Time o.o+o.o 126+76 153+88 201+60 
Weight Loss 
- Jl.2+1.7 J0.0+2.1 J2.9+J.O 
1. Rats were dependent upon 405 mg/kg/day of morphine sulf'ate. 
2. lmA 15 sec nigro-striatal lesions. 
J. 2mA JO sec nigro-striatal lesions. 
Addicted 
Small 2 Lesion 
Large J 
Lesion 
5 lJ.4+4.J 17.5+3.75 
O.J+O.l 0.8+0.8 
20/20 7/7 
6 6 1Jl0+12J6 1414+2556 
54.4+2.4 51.7+J.4 
4. Significantly different from non-lesioned controls based on Student's 't' test (pL0.02) 
5. Significantly different from non-lesioned controls based on Student's 't' test (pL0.01) 
6. Significantly different from non-lesioned controls based on Student's 't' test (pL0.001) 
7. All data are expressed in terms of means and standard errors unless otherwise indicated. 
The nwnber of animals employed in each group is indicated as the denominator of the 
fraction used to express the occurrence of piloerection. Ptosis time is expressed in 
seconds, weight loss in grams and hypothermia in degrees centigrade. 
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after being injected with apomorphine, re-observed. The re-
sults for this experiment are given in Table 8. The paired 
't' test was used to determine if apomorphine had a signif-
icant effect on the symptoms of narcotic withdrawal. Wet 
shakes were significantly (p L 0. 05) reduced by apomorphine 
(l.25 mg/kg) at 24, 48 and 72 hours after the terminal dose 
of morphine. The other symptoms of morphine withdrawal were 
not significantly affected by this treatment. 
2. Effect of apomorphine on narcotic withdrawal symp-
toms in rats with nigro-striatal lesions made after the pro-
duction of dependence. 
Small (lmA 15 sec ) nigro-striatal lesions pcoduced 
after the terminal dose of morphine were observed to in-
crease the severity of the withdrawal syndrome. (See Table 
5.) The effect of an injection of apomorphine (l.25 mg/kg) 
on the withdrawal syndrome in rats with nigro-striatal le-
sion made after the terminal dose of morphine is shown in 
Table 9 . Wet shakes were decreased at 24, 48 and 72 hours 
with significant (pto.05) reductions occurring at both 48 
and 72 hours when compared by the paired 't' test to pre-
drug levels. Apomorphine failed to significantly affect 
the other symptoms of withdrawal in these lesioned rats. 
2) Modification of Narcotic Withdrawal Symptoms by Medial 
Fore Brain Bundle Lesions 
a.. Lesions made after the production of morphine de-
pendence 
Table 8. The Effect of Apomorphine on Narcotic Withdrawal Symptoms in the Intact Dependent 
Rat 
Time Since the Terminal Dose of Morphine 
Twenty-four hours 
S}:'.:mEtoms 5 
Post 1 
.Pre-Drug AEomo q:~hine 
Wet Shakes 6.2+1.5 2.0+1.l 3 
Writhing 1.1+0.J o.4+0.1 
Piloerection 21/21 
(No positive/no observed) 
21/21 
Ptosis Time 434+112 867+134 
Hypothermia 2.08+0.34 2.48+0.30 
Weight Loss 25.0+l.8 25.4+2.o 
Forty-eight hours 
Post 
Pre-Drug A:eomor:ehine 
5.1+1.9 2.8+1.l 4 
l.h+o.5 1.3+0.4 
10/10 10/10 
125+51 379+114 
1.95+0.35 1.92+0.35 
31.h+J.5 33.J+3.9 
1 
Seventy-two hours 
Post 1 Pre-Drug Apomorphine · 
5.6+0.9 
l.J+0.4 
10/10 
3 3.0+0.8 
o.6+o.4 
10/10 
95+63 157+58 
1.24+0.39 l.lO+O.J8 
27.6+3.o Jl.l+J.l 
1 • . Apomorphine hydrochloride 1.25 mg/kg administered fifteen minutes prior to observation. 
2. Rats were dependent upon 405 mg/kg/day of morphine sulfate, injections were given 
three times a day. 
J. Significantly different from pre-drug based on Paired 't' test (p Lo.05). 
4. Significantly different from pre-drug based on Paired 1 t 1 test (p L.. o. 01). 
5. All data are expressed in terms of means and standard errors unless otherwise indi-
cated. The number of animals employed in each group is indicated as the denominator 
of the fractions used to express the occurrence of piloerection. Ptosis time is ex-
pressed in seconds, weight loss in grams and hypothermia in degrees centigrade. 
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Table 9. The Effect of Apomorphine1 on Narcotic Withdrawal Symptoms in Rats With Nigro-
Striatal Lesions2 Made After the Terminal Dose of Morphine3 
Time Since the Terminal Do se of Morphine Sulfate 
Twenty-four hours Forty-eight hours Seventy-two hours 
SymEtoms5 
Post 1 Post 1 Pre-Drug: Apomorphine Pre-Drug AEomorEhine Pre-Drug 
Post 1 Apomorphine 
Wet Shakes 15. l+lt. l 7.8+1.5 
Writhing 0.7+0.4 O.O+O.O 
Piloerection 9/9 
(No positive/No observed) 
9/9 
Ptosis Time 1800+0 1800+0 
Hypothermia 2.J+0.4 2.8+0.2 
Weight Loss J0.7+2.2 J6 .2+2.0 
l.).O+J.l 
o.4+o.4 
9/9 
1800+0 
J.8+0.5 
60.1+2.J 
6.0+l.4 4 
o.o+o.o 
9/9 
1785+14-
4.J+0.4 
6J.0+2.0 
9.l+J.8 
o.o+o.o 
8/8 
1800+0 
6.4+0.9 
81. O+J. 0 
4 2.5+1.l 
o.o+o.o 
8/8 
1740+35 
6.6+0.9 
81.6+2.4 
1. Apomorphine hydrochloride 1.25 mg/kg administered fifteen minutes prior to observation. 
2. lmA 15 sec nigro-striatal lesions. 
J. Rats were dependent upon 405 mg/kg/day of morphine sulfate, injections were given 
twice a day. 
4. Significantly different from pre-drug based on Paired 1 t 1 test (p LO. 05). 
5. All data are expressed in terms of means and standard errors unless otherwise indi-
ca.ted. The number of animals employed in each group is indicated as the denominator 
of the fractions used to express the occurrence of piloe rection. Ptosis time is ex-
pressed in seconds , weight loss in grams and hypothermia in degrees centigrade. 
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1. Effect of small medial fore brain bundle lesions 
Withdrawal symptoms were found to be modified 
by small (lmA 15 sec ) medial fore brain bundle lesion 
when they were made after the terminal dose of morphine; 
these results are shown in Table 10. The Student's 't' test 
was used to analyze the difference between the mean of the 
lesioned groups and that of the non-lesioned addicted con-
trols. Wet shakes were found to be significantly (pL 0.05) 
increased at 48 hours of withdrawal while writhing was sig-
nificantly (pL0.02) decreased at both 24 and 48 hours after 
the terminal dose of morphine. Significant (pL 0. 001) in-
cre~ses were seen in ptosis time and weight loss at 24, 48 
and 72 hours of morphine withdrawal. Hypothermia was found 
to significantly (p.LO.Dl) increase at 72 hours of morphine 
withdrawal. The lesion by itself produced ptosis and weight 
loss in non-addicted rats. Medial fore brain bundle lesions 
were found to decrease soci~l aggression seen at 72 hours 
of withdrawal; these results are shown in Table 4. 
2. Effect of large medial fore brain bundle lesions 
The effect of large (2mA JO sec ) medial fore 
brain bundle lesion on morphine withdrawal are shown in 
Table 10. At 48 hours of withdrawal a significant (p.L0.001) 
increase in wet shakes was observed; the Student's 't' test 
was used to determine significance. Writhing was signifi-
cantly (pL0.05) decreased at both 48 and 72 hours of with-
drawal. The Student's 't' test showed ptosis time and 
weight loss to be significantly (pL0.001) increased in the 
Table 10. The Effect of' Medial Fore Brain Bundle Lesions on the Narcotic Withdraw! Syndrome 
Non Addicted 
Symptoms5 
(Hours of' 
W:ithdrawal 
Wet Shakes 
24 
48 
72 
Writhing 
24 
48 
72 
Piloerection 
Non 
Lesioned 
0.2+0.3 
0.2±0.3 
0.2±0.3 
o.o+o.o 
o.o.±.o.o 
o.o.±.o.o 
{No positive/No observed) 
24 0/12 
48 0/12 
72 0/12 
Ptosis Time 
24 
48 
72 
o.o+o.o 
o.o+o.o 
o.o+o.o 
Lesioned 
lmA 15 sec 
1.25+0.7 
0.75+0.3 
1.25.±.0.9 
0.75+0.3 
0.62+0.2 
0.62+0.3 
5/8 
5/8 
8/8 
562+2152 
615-:;:-2841 
576+258 
2mA JO sec 
0.7+0.4 
2.0+0.8 
1.1±0.9 
o.o+o.o 
O.J+0.3 
o.o+o.o 
2/L~ 
5/6 
4/6 
570±]96 
1600+1264 
1058+3393 
Addicted 
Non 
Lesioned 
9.1+1.3 
6.9+0.8 
6.3+0.9 
1.9+0.3 
2.5+0.4 
J.2±0.9 
27/27 
27/27 
16/16 
101.±.27 
87+30 
201+60 
Lesioned 
lmA 15 sec 2mA JO sec 
10.1+3.4 
14.5+3.0 
8.8±2.7 
4 0.3+0.2 
4.5+2.6 
0 .. 50+0.32 
6/6 
6/6 
6/6 
4 
1533+1?84 
1033.±.2b04 
1270±.255 
10.2.±.4.84 
16.5+2.l 
20.0.±.8.6 
0.2+0.2 
- 1 0.1+0.1 
- 1 0.0±0.0 
8/8 
7/7 
4/4 
4 1800±0004 
1611±1444 
1800+000 
I-' 
~ 
Table 10 ~ Continued 
Hypothermia 
24 
48 
72 
Weight Loss 
24 
48 
72 
O.Ol+0.08 
+0.08+0.16 
O.Jl+0.11 
4J.2+2.0 
61.7:;2.5 
67.5+6.5 
+O.l+O.l 
O.O+O.l 
o.4:;0.2 
L~5.4+4.J 
62.J+4.9 
72.8+6.4 
2.04+0.07 
1.8+0.0J 
l.J5+0.l 
12.4+1.4 
25.5+1.6 
J2.8+J.O 
l.5J+O.J9 
l.90+0.J6 
J.J0+0.573 
4 J6.8,±.l.74 
59. 6±1. 61+ 
7J.8±.l.7 
2.50+1.92 
4.62+0.9 
- 2 4.67±2-5 
4 J9.6±_2.24 
59.4±.J.64 
62.7±.7.1 
1. Significantly different from non-lesioned controls based on Student's 't' test 
(pL0.05). 
2. Significantly different from non-lesioned controls based on Student's 't' test 
(p L0.02). 
J. Significantly different from non-lesioned controls based on Student's 't' test 
(pL 0.01). 
4. Signi f icantly different from non-lesioned controls based on Student's 't' test 
(p.L0.01). 
5. All data are expressed in terms of means and standard errors unless otherwise indi-
c at e d. The number of a nima ls employed in each group is indicated as the d e nominator 
of th~ fractions used to express the occurrence of piloerection. Ptosis time is ex-
press e d in seconds, weight loss in grams and hypothermia in degrees centigrade. 
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medial fore brain lesioned withdrawn rats. Hypothermia was 
significantly (p £ 0. 02) increased in the lesion groups. 
Ptosis and weight loss resulted from lesioning non-addicted 
rats. Morphine withdrawal a g gression was decreased by these 
_large medial fore brain bundle. 
ized in Table 4. 
These results are sununar-
b. Small lesions made during the withdrawal period 
The effects of small (lmA 15 sec ) medial fore bra in 
bundle lesions made at 48 hours on narcotic withdrawal 
symptoms at 72 hours are sununarized in Table 11. Statistical 
significance was determined by the Student's 't' test. 
Ptbsis time, weight loss and hypothermia were found to sig-
nificantly (p Lo.01) increase in medial fore bra in bundle 
lesioned rats as compared to non-lesioned addic ted controls. 
D. Discussion 
The results from these experiments sugge s t a role for 
dopaminergic nigro-stria tal fibers in mori:,hine ivi thdrawal . 
Nigro-striatal lesioning prior to the production of mor-
phine dependence resulted in increased wet shakes, ptosis 
and weight loss at various intervals after the terminal 
doses of morphine. Similar increases in wi thdrawa_l symptoms 
were observed when small (lmA 15 sec ) lesions of the nigro~ 
striatal pathway were made after the terminal dose of mor-
phine. Ptosis time, weight loss and hypothermia were in-
creased when large (2rnA JO sec ) nigro-striatal pathway le-
sions were produced after the production of morphine depend-
ence. Lesions of the nigro-s t riatal bundle during the 
Table l _l. Narcotic Withdrawal Symptoms at Seventy-Two Hours After Small Lesions of the 
Medial Fore Brain Bundle1 at Forty-Eight Hours 
Non Addicted Addicted 
-
Symptoms7 
Non 
Lesioned2 
Non 
Lesioned4 Le sioned LesionedJ 
Wet Shakes 0.2+0.J 2 .6+0.7 6.J+0.6 6.1+0.9 
Writhing O.O+O.O 0.8+0.3 3.2+0.9 1.5+1.2 
Piloerec tion 0/12 0/12 16/16 16/16 
(No positive/No observed) 1043+164~ Ptosis Time O.O+O.O J8J+208 201+60 
Weight Loss - Jl.9+.08 J2.9+J.O 52.6+J.46 
Hypothermia 
-
O.Ol+.08 1.35+0.l 2.97+0.4 
1. lmA 15 sec medial fore brain bundle lesions. 
2. Twenty-four hours after medial fore brain bundle lesioning. 
J. Seventy-two hours after the last injection of morphine sulf'ate, 135 mg/kg. 
4. Seventy-two hours after the last injection of morphine sulfate, 135 mg/kg, and 
twenty-four hours after the production of the lesion. 
5. Significantly different from non-lesioned addic ted controls by the Student's It I 
test (p L 0,02). 
6. Significantly different from non-lesioned addicted controls by the Student's It I 
test (p L0 .01). 
7. All data are expressed in terms of means and standard errors unless otherwise indi-
cated. The number of animals employed in e2ch group is indicated as the denominator 
of the fractions used to express the occurrence of piloerection. Ptosis time is ex-
pressed in seconds, weight loss in grams and hypothermi a in degrees centigrade. 
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withdrawal period, 48 hours after the terminal dose of mor-
phine, resulted in increased wet shakes,ptosis time and 
weight loss. Apomorphine, a dopamine receptor agortist 
(Anden tl al., 1967; Ernst, 1967), reduced "\'!et shakes in 
both intact and nigro-striatal lesioned dependent rats. 
Several mechanisms may possibly underly the enhanced 
withdrawal symptoms in nigro-striatal lesioned subjects. 
An increased denervation supersensitivity, changes in recep-
tor activity and alterations in the balance between several 
putative neurotransmitters are mechanisms worthy of consid-
eration. 
One possible explanation for the enhanced withdrawal 
symptoms induced by nigro-striatal lesioning can be offered 
in terms of a denervation supersensitivity • . It is a well 
recognized phenomenon that after pharmacological or surgical 
denervation in the peripheral nervous system, the response 
of the target organ to a transmitter can be greatly augmented. 
Analogously, it has been suggested that physical dependence 
might be a manifestation of a central denervation super-
sensitivi ty and as a result the withdrawal phenomena would 
reflect a state of rebound hyperexcitability (Jaffee and 
Sharpless, 1968). If the withdrawal symptoms that were seen 
to increase involve dopaminergic pathways, then nigro-
striatal lesioning could induce an additional degree of 
supersensitivity in this pathway and thus enhance the with-
drawal symptoms. The production of a biochemical lesion of 
catecholamine nerve terminal by 6-hydroxy-·dopamine has been 
reported to exacerbate the signs of morphine withdrawal in 
mice {Friedler et al., 1972) and in rats (Bhargava et al., 
111 
1973). These investigators have suggested that the enhanced 
withdrawal phenomena observed in their experiments may be 
due to an increased denervation supersensitivity produced 
by 6-hydroxydopamine treatment. 
Receptor activation may be in part responsible for the 
expression of several withdrawal symptoms. Nigro-striatal 
lesions lead to increased wet shakes and a decreased activa-
tion of striatal dopamine receptors, whereas apomorphine, a 
dopaminergic receptor stimulant, decreases the occurrence 
of wet shakes. These data point to a major role for dopa-
mine receptor activity in the expression of narcotic with-
drawal wet shakes. An increase in dopamine receptor activity 
resulting in decreased symptomology while on the hand de-
creased receptor stimulation results in the increased oc-
currence of wet shakes. The apomorphine induced decrease 
of withdrawal wet shakes is in accordance with the results 
of Hoffmeister and Schichting (1973). These investigators 
found a decrease in withdrawal wet shakes of the dog after 
stimulation of central catecholamine mechanisms with amphet-
amine and cocaine. The effect of these drugs was inter-
preted to indicate an antagonism of withdrawal. Herz ~ al., 
(1974) have shown that the administration of ct-amphetamine, 
cocaine, L-dopa increased levallophan precipitated withdraw-
al jwnping and decreased wet shakes. The effect of these 
drugs was interpreted as a potentiation of withdrawal since 
similar changes in withdrawal occurred when. withdrawal was 
precipitated in highly dependent rats (Herz et al., 1974). 
Following their logic it would be concluded that nigro-
st~iatal lesions reduce narcotic withdrawal. This conclu-
sion does not seem to be justified in view of the fact that 
rats receiving a terminal dose of 405 mg/kg/day of morphine 
show a higher occurrence of wet shakes than those dependent 
upon 200 mg/kg/day of morphine. It has been reported that 
rats de~endent upon JO or 120 mg/kg/day of morphine show no 
wet shakes upon withdrawal of the drug (Akera and Brady, 
1968). The increase in wet shakes se e n in those rats re-
ceiving a higher terminal dof.e of morphine tends to parallel 
a general increase in other s~nptoms. 
Additional support for the role of denervation super-
sensitivity and receptor activity in the expression of 
withdrawal symptoms comes from the effect of the lesion by 
itself. Nigro-striatal lesioning produced some symptoms 
similar to those of narcotic withdrawal. Lesioned animals 
showed wet shakes, writhing, piloerec t ion, ptosis and 
weig;ht loss. The appearance of these withdrawal like symp-
toms is thought to be due to a decrease impulse flow in the 
nigro-striatal system and a resultant denervation super-
sensitivity. It should be pointed out that the increase in 
withdrawal symptoms in the animals lesioned after the pro-
duction of dependence cannot totally be explained in terms 
of the lesion effect a lone. Lesioning t he nigro-striatal 
pathway prior to the production of dependence results in 
llJ 
increased withdrawal signs when the effect of the lesion alone 
is virtually non-exist e nt. 
Alterations in the balance between several putative 
neurotransmitters have been reported to occur during morphine 
withdrawal (Merali ~al., 1974). These inv estigators have 
shown alterations in the cholinergic and dopaminergic mech-
anism of the striatum during chronic morphine treatment and 
its subsequent withdrawal. Dopaminergic nigro-s t riatal fi-
bers are known to influence the metabolism of acetycholine 
in the neostriatum. Destruction of this tract results in an 
exaggerated response in neostriatal cholinergic neurons to 
apornorphine (Fibiger and Grewaal, 1974). A complex interac-
ti,:>n between morphine induced changes in striatal dopamine 
and acetycholine and tho se cha nges induced by nigr6-striatal 
lesioning may be in part responsible for the enhanced with-
drawal symptoms observed in nigro-striatal lesioned sub-
jects. Serotonin has also been implicated in the pharma-
cological actions of morphine and in the phenomena of narcot-
ic withdrawal (Shen~ al., 1970)~ Recently it has been 
shown that nigro-striatal fibers are functionally connected 
with a serotonergic system (Cools~ al., 1974). It is thus 
possible that the nigro-striatal les i on induced increases 
in withdrawal symptoms are the result of alterations in sero-
tonergic and dopamine rgic neuronal systems. 
The intense morphine withdrawal a ggression observed in 
response to social g rouping 7 2 hours after the termination 
of morphine injections was reduced by the production of 
114 
partial nigro~striatal lesion prior to the production of de-
pendence. Similarly, when lesions of the nigro-striatal 
tract were made after the terminal dose of morphine there was 
a general decrease in the aggressive response of these ani-
mals. One notable exception occurred when a small (lmA 15 
sec.) lesion was placed in rats dependent upon 200 mg/kg/day 
morphine after the last injection. It should be noted that 
these results are of a preliminary nature and further investi-
gation is needed. These results are thus in agreement with 
those of Gianutsos ~ ~· (1973, 1974b),who have shown that 
nigro-striatal lesioning blocked morphine withdrawal aggres-
sion in thirty-'-day abstinent rats. It has been previously 
hy;iothesized that social aggression during acute w.ithdrawal 
was caused by the hyperactivity of dopaminergic receptors 
which have become supersensitized during chronic morphine 
administration (Lal .~~., 1971; Lal and Puri, 1972; Puri 
and Lal, 1973). The decrease in aggression.appears to re-
sult from the degeneration of dopamine neurons produced by 
the lesion, thus leaving little or no transmitter to be re-
leased onto supersensitized receptors. 
Destruction of the medial fore brain bundle in morphine 
dependent rats resulted in increased ptosis, temperature and 
weight loss. Although wet shakes were seen to increase at 
both 48 hours and 72 hours, the increase was significant on-
ly at 48 hours. Seventy-two hour withdrawal ptosis, weight 
and temperature loss were significantly increased when le-
sions were produced during the withdrawal period. Wet shakes 
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were not affected by these 48 hour lesions~- These experi-
ments with the medial fore brain bundle suggest a role for 
nor-adrenergic and serotonergic mechanisms in narcotic with~ 
drawal, especially ptosis, weight a n d temperature loss. The 
involvement of the media l fore brain b undle in n a rcotic 
withdrawal has been previously sug gested (Glick et al., 1973; 
Herz et al., 1974). It appears that wet shakes are more de-
pendent upon dopaminergic mechanisms, since medial · fore brain 
bundle lesions were effected in significantly increasing wet 
shakes at only one time interval. A role for this noradren-
ergic neuronal system in wet shakes can not be totally ruled 
out. 
VI. DISCUSS!OK 
Electrolytic lesions of the nigro-striatal dopamine 
pathway resulted in decreased striatal dopamine, loss of 
body weight and increased some symptoms of morphine with-
drawal. 
Increased levels of striatal dopamine were seen 24 
hours after both small (lmA 15 sec) and large (2mA JO sec) 
lesions of the nigro-striatal tract .• At four and seven days 
after small (lmA 15 sec) lesions the level of striatal dop-
amine was significantly reduced. A similar reduction was 
otserved four days following a large (2rnA JO sec) nigro-
striatal lesion. These results correspond well with those 
of other investigators (Faull~ al., 1969; Anden ~al., 
1972; Agid et al., 1974). 
Lesioning of the nigro-striatal pathway resulted in 
aphagia and adipsia, indicated by a loss of body weight. 
The histological examination of · the lesion site and the de~ 
crease in corpus striatal dopamine produced by the lesion 
indicates that the extent of weight loss was dependent upon 
the amount of nigro-striatal damage. Administration of 
haloperidol or alpha-methyl-para-tyrosine prior to the pro-
duction of small (lmA 15 sec) nigro-striatal lesions les-
sened the loss in body weight produced by the lesion. 
Lethality and the loss of body weight were reduced in those 
animals who were pretreated with haloperidol and morphine 
116 
ll-1 
prior to receiving a large (2mA JO sec ) nigro-striatal le-
sion. An increase in receptor sensitivity, regnerative 
sprouting from transected axons and an increase in catechol-
amine turnover are several possible mechanisms which may be 
involved in the recovery of body weight following nigro-
striatal lesioning. 
Morphine withdrawal wet shakes, ptosis, weight loss 
and hypothermia were increased when nigro-striatal lesions 
were made either prior to or following . the production of mor-
phine dependence. Similar changes were observed when the 
lesion was made during the withdrawal period. Apomorphine 
effectively induced withdrawal wet shakes in both in~act and 
nigro-striatal lesioned subjects. Several mechanisms which 
may be responsible for the enhanced withdrawal symptoms in 
these lesioned subjects are an increased denervation super-
sensi tivi ty, changes in receptor activity and alterations 
in the balance between several putative neurotransmitters. 
Noradrenergic mechanism also appears to be involved in the 
narcotic withdrawal syndrome since destruction of the medial 
fore brain bundle in morphine dependent rats resulted in in-
creased ptosis, weight loss and hypothermia. 
This study suggests a role for nigro-striatal fibers 
in the regulation of body weight and some of the symptomol-
ogy of morphine withdrawal. An interaction between the 
nigro-striatal system and drugs effect dopamine receptors 
is indicated by the pharmacological modification of lesion 
induced weight lo ss. The increased morphine withdrawal 
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wet shakes, ptosis, hypothermia, weight loss and decreased 
aggression further suggest such an interaction. The 
supersensitivity of dopamine receptors may be a useful con-
cept in explaining such interactions. 
:VII. SUMMARY AND CONCLUSIONS 
Lesions of the nigra-striatal dopamine neurons system 
result in aphagia and adipsia. The extent of weight loss 
in the lesioned animals was dependent upon the amount of 
nigro-striatal damage. A denervation supersensitivity of 
striatal dopamine receptors is viewed as being in part re-
sponsible for the recovery of nutritive function following 
nigro-striatal destruction. Administration of drugs cap-
able of producing supersensitivity at central dopamine re-
ceptors, alpha-methyl-para-t :;.Tosine, haloperidol and mor-
phine, have been found to facilitate recovery from the le-
sion effects. 
The symptoms of morphine withdrawal were intensified 
when the nigro-striatal pathway was destroyed prior to or 
following the production of dependence. Withdrawal wet 
shakes, ptosis, weight loss and temperature loss were seen 
to significantly increase. Apomorphine produced a signif-
icant decrease in wet shakes in both lesioned and non-
lesioned dependent rats. These results suggest that with-
drawal wet shakes are dependent upon dopaminergic mecha-
nism. A denervation supersensitivity mechanism, changes 
in receptor activity and alterations in the balance between 
several putative neurotransmitters are mechanisms which may 
be useful in explaining the increased withdrawal phenomena. 
119 
] 20 
Nigro-striatal destruction was found to hav·e decreased the 
intensity of seventy-two hour withdrawal agg ression. 
Noradrenerg ic mechanisms also appear to be involved 
in the narcotic withdrawal syndrome. The symptoms of ptosis, 
weight and temperature loss appear to be at least in part 
dependent upon the activity and functional integrity of th~ 
medial fore brain bundle. 
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